Sulfate-free personal cleansing composition with effective preservative properties - Patents.com
A sulfate-free personal cleansing composition using sulfate-free surfactants, lauramidopropyl betaine, and cationic polymers forms a coacervate phase to ensure effective preservative properties and consumer safety, addressing the need for reduced preservatives and improved cleansing performance.
Patent Information
- Application Number
- JP2024534053
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-12-09
- Filing Date
- 2022-12-09
- Publication Date
- 2024-11-28
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
There is a need for sulfate-free personal cleansing compositions that maintain effective preservative properties while reducing the amount of preservatives to address consumer concerns about microbial growth and resistance, while also providing acceptable cleansing and foaming performance.
A personal cleansing composition comprising sulfate-free surfactants, lauramidopropyl betaine, cationic polymers, stabilizing polymers, and a preservative, with a pH range of 5 to 7, which forms a coacervate phase to enhance microbial stability and consumer safety.
The composition achieves effective microbial preservative properties with reduced preservative use, maintaining product quality and consumer safety, while providing satisfactory cleansing and foaming performance.
Smart Images

Figure 2024544222000001 
Figure 2024544222000002 
Figure 2024544222000003
Abstract
Description
[Technical field]
[0001] The present disclosure relates generally to sulfate-free personal cleansing compositions formulated with scalp actives, amphoteric surfactants, and cationic polymers that maintain acceptable antiseptic properties. [Background technology]
[0002] Preservatives are substances added to personal cleansing compositions, such as shampoos, body washes, body lotions, ointments, creams, and topicals, to inhibit the growth of microorganisms, which may result from, for example, consumer contamination during use. Inhibiting the growth of microorganisms, such as bacteria and fungi, is of paramount importance to maintain product quality, extend shelf life, and protect consumers. There is a continuing desire from consumers to reduce the amount and / or number of preservatives used in consumer products. On the other hand, exposure of microorganisms to insufficient concentrations of preservatives or antibacterial agents can lead to the selection or emergence of resistant bacteria. Therefore, there is a need to use preservatives that are high enough in concentration to inhibit microbial growth and maintain product quality, but low enough in concentration to alleviate consumer concerns. Summary of the Invention [Problem to be solved by the invention]
[0003] Surprisingly, it has been discovered that a single preservative can provide effective microbiological preservative properties to a personal cleansing composition while simultaneously meeting consumer demands for less preservatives. It has also been determined which ingredients and combinations of ingredients provide micro robustness. [Means for solving the problem]
[0004] The present invention is directed to a personal cleansing composition comprising from about 6% to about 50% of one or more sulfate-free surfactants, from about 0.5% to 20% lauramidopropyl betaine, from about 0.1% to about 10% zinc pyrithione, from about 0.05% to about 3% of a cationic polymer, from about 0.05% to 10% of a stabilizing polymer, from about 0.1% to about 2% of a preservative, and having a pH of from about 5 to about 7. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0005] While the specification concludes with claims which particularly point out and distinctly claim the invention, it is believed the present disclosure will be better understood from the following description.
[0006] As used herein, the term "fluid" includes liquids and gels.
[0007] As used herein, the articles including "a" and "an," when used in a claim, are understood to mean one or more of what is claimed or described.
[0008] As used herein, "comprising" means that other steps and other ingredients that do not affect the end result can be added. This term encompasses the terms "consisting of" and "consisting essentially of."
[0009] As used herein, "mixture" is meant to include simple combinations of materials and any compounds that may result from those combinations.
[0010] As used herein, "molecular weight" or "M.Wt." refers to weight average molecular weight, unless otherwise noted. Molecular weight is measured using gel permeation chromatography (GPC), an industry standard method. Molecular weight has units of grams per mole.
[0011] As used herein, "cleansing composition" includes personal cleansing products such as shampoos, conditioners, conditioning shampoos, shower gels, liquid hand washes, facial cleansers, and other surfactant-based liquid compositions.
[0012] As used herein, the terms "include", "includes", and "including" are meant to be open-ended and are understood to mean "comprise", "comprises", and "comprising", respectively.
[0013] All percentages, parts and ratios are based on the total weight of the compositions of the present invention unless otherwise specified. All such weights as they pertain to listed ingredients are based on the active level and, therefore, do not include carriers or by-products that may be included in commercially available materials.
[0014] Unless otherwise noted, all component or composition concentrations are in terms of the active portion of that component or composition and are exclusive of impurities, e.g., residual solvents or by-products, that may be present in commercial sources of such component or composition.
[0015] It should be understood that every maximum numerical limitation given throughout this specification includes every lower numerical limitation, as if such lower numerical limitation were expressly written herein. Every minimum numerical limit given throughout this specification includes every higher numerical limitation, as if such higher numerical limitations were expressly written herein. Every numerical range given throughout this specification includes every narrower numerical range that falls within such broader numerical range, as if such narrower numerical ranges were all expressly written herein.
[0016] A. Surfactants The cleansing composition described herein may include one or more surfactants in the surfactant system. The one or more surfactants may be substantially free of sulfate-based surfactants. As can be understood, the surfactant provides a cleaning effect on soiled items such as hair, skin, and hair follicles by facilitating the removal of oil and other soils. The surfactant generally facilitates such cleaning due to its amphiphilic nature, which allows the surfactant to break down and form micelles around the oil and other soils, which can then be rinsed away, thereby removing them from the soiled items. Suitable surfactants for the cleansing composition may include an anionic portion that allows the formation of coacervates with the cationic polymer. The surfactant may be selected from anionic surfactants, amphoteric surfactants, zwitterionic surfactants, nonionic surfactants, and combinations thereof.
[0017] Cleansing compositions typically use a sulfate-based surfactant system (such as, but not limited to, sodium lauryl sulfate) for its effectiveness in foam production, stability, clarity, and cleansing. The cleansing compositions described herein are substantially free of sulfate-based surfactants. As used herein, "substantially free" of sulfate-based surfactants means about 0% to about 3% by weight, alternatively about 0% to about 2% by weight, alternatively about 0% to about 1% by weight, alternatively about 0% to about 0.5% by weight, alternatively about 0% to about 0.25% by weight, alternatively about 0% to about 0.1% by weight, alternatively about 0% to about 0.05% by weight, alternatively about 0% to about 0.01% by weight, alternatively about 0% to about 0.001% by weight, and / or alternatively no sulfate. As used herein, "free" means 0% by weight.
[0018] Additionally, the surfactant systems described herein may have from about 0% to about 1% by weight of inorganic salts.
[0019] Additionally, the surfactant can be added to the composition as a solution rather than as a neat material, and the solution may include an inorganic salt that can be added to the formulation. The surfactant formulation may have an inorganic salt that can be about 0% to about 2%, alternatively about 0.1% to about 1.5%, alternatively about 0.2% to about 1% of the inorganic salt in the final composition.
[0020] Suitable surfactants that are substantially free of sulfates can include sodium, ammonium, or potassium isethionates; sodium, ammonium, or potassium sulfonates; sodium, ammonium, or potassium ether sulfonates; sodium, ammonium, or potassium sulfosuccinates; sodium, ammonium, or potassium sulfoacetates; sodium, ammonium, or potassium glycinates; sodium, ammonium, or potassium sarcosinates; sodium, ammonium, or potassium glutamates; sodium, ammonium, or potassium alaninates; sodium, ammonium, or potassium carboxylates; sodium, ammonium, or potassium taurates; sodium, ammonium, or potassium phosphate esters; and combinations thereof.
[0021] The concentration of surfactant in the composition should be sufficient to provide the desired cleansing and lathering performance. The cleansing composition may have a total surfactant concentration of about 6% to about 50% by weight, about 5% to about 35% by weight, about 10% to about 50% by weight, about 15% to about 45% by weight, about 20% to about 40% by weight, about 22% to about 35% by weight, and / or about 25% to about 30% by weight.
[0022] The surfactant system may comprise one or more amino acid-based anionic surfactants.Non-limiting examples of amino acid-based anionic surfactants may include sodium, ammonium or potassium salt of acylglycinate; sodium, ammonium or potassium salt of acylsarcosinate; sodium, ammonium or potassium salt of acylglutamate; sodium, ammonium or potassium salt of acylalaninate; and combinations thereof.
[0023] The amino acid anionic surfactant can be a glutamate, such as an acyl glutamate. The composition can include an acyl glutamate concentration of about 2% to about 22% by weight, about 3% to about 19% by weight, about 4% to about 17% by weight, and / or about 5% to about 15% by weight.
[0024] Non-limiting examples of acyl glutamates include sodium cocoyl glutamate, disodium cocoyl glutamate, ammonium cocoyl glutamate, diammonium cocoyl glutamate, sodium lauroyl glutamate, disodium lauroyl glutamate, sodium cocoyl hydrolyzed wheat protein glutamate, disodium cocoyl hydrolyzed wheat protein glutamate, potassium cocoyl glutamate, dipotassium cocoyl glutamate, potassium lauroyl glutamate, dipotassium lauroyl glutamate, potassium cocoyl hydrolyzed wheat protein glutamate, dipotassium cocoyl hydrolyzed wheat protein glutamate, sodium capryloyl glutamate, disodium capryloyl glutamate, potassium capryloyl glutamate, dipotassium capryloyl glutamate, sodium undecylenoyl glutamate, disodium undecylenoyl glutamate, potassium undecylenoyl glutamate, undecylenoyl The glutamate may be selected from the group consisting of dipotassium glutamate, disodium hydrogenated tallow glutamate, sodium stearoyl glutamate, disodium stearoyl glutamate, potassium stearoyl glutamate, dipotassium stearoyl glutamate, sodium myristoyl glutamate, disodium myristoyl glutamate, potassium myristoyl glutamate, dipotassium myristoyl glutamate, cocoyl / hydrogenated tallow glutamate, cocoyl / palmoyl / sunfloweroyl sodium glutamate, hydrogenated tallow glutamate, sodium olivoyl glutamate, disodium olivoyl glutamate, sodium palmoyl glutamate, disodium palmoyl glutamate, TEA-cocoyl glutamate, TEA-hydrogenated tallow glutamate, TEA-lauroyl glutamate, and mixtures thereof.
[0025] The amino acid-based anionic surfactant may be an alaninate, such as an acyl alaninate. Non-limiting examples of acyl alaninates include sodium cocoyl alaninate, sodium lauroyl alaninate, sodium N-dodecanoyl-l-alaninate, and combinations thereof. The composition may have an acyl alaninate concentration of about 2% to about 20% by weight, about 7% to about 15% by weight, and / or about 8% to about 12% by weight.
[0026] The amino acid-based anionic surfactant may be a sarcosinate, such as an acyl sarcosinate. Non-limiting examples of sarcosinates include sodium lauroyl sarcosinate, sodium cocoyl sarcosinate, sodium myristoyl sarcosinate, TEA-cocoyl sarcosinate, ammonium cocoyl sarcosinate, ammonium lauroyl sarcosinate, dimer dilinoleyl bis-lauroyl glutamate / lauroyl sarcosinate, disodium lauroamphodiacetate lauro ... sarcosinate), isopropyl lauroyl sarcosinate, potassium cocoyl sarcosinate, potassium lauroyl sarcosinate, sodium cocoyl sarcosinate, sodium lauroyl sarcosinate, sodium myristoyl sarcosinate, sodium oleoyl sarcosinate, sodium palmitoyl sarcosinate, TEA-cocoyl sarcosinate, TEA-lauroyl sarcosinate, TEA-oleoyl sarcosinate, TEA-palm kernel sarcosinate, and combinations thereof.
[0027] The amino acid based anionic surfactant can be a glycinate, such as an acyl glycinate. Non-limiting examples of acyl glycinates include sodium cocoyl glycinate, sodium lauroyl glycinate, and combinations thereof.
[0028] The composition may contain an additional anionic surfactant selected from the group consisting of sulfosuccinates, isethionates, sulfonates, sulfoacetates, glucose carboxylates, alkyl ether carboxylates, acyltaurates, and mixtures thereof.
[0029] Non-limiting examples of sulfosuccinate surfactants may include disodium N-octadecyl sulfosuccinate, disodium lauryl sulfosuccinate, diammonium lauryl sulfosuccinate, sodium lauryl sulfosuccinate, disodium laureth sulfosuccinate, tetrasodium N-(1,2-dicarboxyethyl)-N-octadecyl sulfosuccinate, diamyl ester of sodium sulfosuccinate, dihexyl ester of sodium sulfosuccinate, dioctyl ester of sodium sulfosuccinate, and combinations thereof. The composition may have a sulfosuccinate concentration of about 2% to about 22%, about 3% to about 19%, about 4% to about 17%, and / or about 5% to about 15% by weight.
[0030] Suitable isethionate surfactants may include the reaction product of fatty acid esterified with isethionic acid and neutralized with sodium hydroxide.Suitable fatty acids for isethionate surfactants may be derived from coconut oil or palm kernel oil, including amides of methyl tauride.Non-limiting examples of isethionates may be selected from the group consisting of sodium lauroyl methyl isethionate, sodium cocoyl isethionate, ammonium cocoyl isethionate, hydrogenated sodium cocoyl methyl isethionate, sodium lauroyl isethionate, sodium cocoyl methyl isethionate, sodium myristoyl isethionate, sodium oleoyl isethionate, sodium oleyl methyl isethionate, sodium palm kerneloyl isethionate, sodium stearoyl methyl isethionate, and mixtures thereof.
[0031] Non-limiting examples of sulfonates can include alpha olefin sulfonates, linear alkyl benzene sulfonates, sodium lauryl glucoside hydroxypropyl sulfonate, and combinations thereof.
[0032] Non-limiting examples of sulfoacetates can include sodium lauryl sulfoacetate, ammonium lauryl sulfoacetate, and combinations thereof.
[0033] Non-limiting examples of glucose carboxylates can include sodium lauryl glucoside carboxylate, sodium cocoyl glucoside carboxylate, and combinations thereof.
[0034] Non-limiting examples of alkyl ether carboxylates include sodium laureth-4 carboxylate, laureth-5 carboxylate, laureth-13 carboxylate, sodium C12-13 pareth-8 carboxylate, sodium C12-15 pareth-8 carboxylate, and combinations thereof.
[0035] Non-limiting examples of acyltaurates can include sodium methyl cocoyl taurate, sodium methyl lauroyl taurate, sodium methyl caproyl taurate, sodium methyl oleoyl taurate, and combinations thereof.
[0036] The surfactant system may further comprise one or more amphoteric surfactants, which may be selected from the group consisting of betaines, sultaines, hydroxysultans, amphohydroxypropylsulfonates, alkyl amphoactates, alkyl amphodiacetates, and combinations thereof.
[0037] Examples of betaine amphoteric surfactants may include cocodimethyl carboxymethyl betaine, cocoamidopropyl betaine (CAPB), coco betaine, lauryl amidopropyl betaine (LAPB), coco-betaine, cetyl betaine, oleyl betaine, lauryl dimethyl carboxymethyl betaine, lauryl dimethyl alpha carboxyethyl betaine, cetyl dimethyl carboxymethyl betaine, lauryl bis-(2-hydroxyethyl) carboxymethyl betaine, stearyl bis-(2-hydroxypropyl) carboxymethyl betaine, oleyl dimethyl gamma-carboxypropyl betaine, lauryl bis-(2-hydroxypropyl) alpha-carboxyethyl betaine, and mixtures thereof. Examples of sulfobetaines may include cocodimethyl sulfopropyl betaine, stearyl dimethyl sulfopropyl betaine, lauryl dimethyl sulfoethyl betaine, lauryl bis-(2-hydroxyethyl) sulfopropyl betaine, and mixtures thereof.
[0038] Non-limiting examples of alkyl amphoacetates can include sodium cocoyl amphoacetate, sodium lauroyl amphoacetate, and combinations thereof.
[0039] Amphoteric surfactants may include cocamidopropyl betaine (CAPB), lauramidopropyl betaine (LAPB), and combinations thereof.
[0040] The cleansing composition may comprise an amphoteric surfactant concentration of about 0.5% to about 20% by weight, about 1% to about 15% by weight, about 2% to about 13% by weight, about 3% to about 15% by weight, and / or about 5% to about 10% by weight.
[0041] The surfactant system may have a weight ratio of anionic surfactant to amphoteric surfactant of about 0.4:1 to about 1.25:1, may have a weight ratio of anionic surfactant to amphoteric surfactant of about 0.5:1 to about 1.1:1, may have a weight ratio of anionic surfactant to amphoteric surfactant of about 0.6:1 to about 1:1. In some examples, the ratio of anionic surfactant to amphoteric surfactant may be less than 1.1:1, may be less than 1:1.
[0042] The surfactant system may further comprise one or more non-ionic surfactants, which may be selected from the group consisting of alkyl polyglucosides, alkyl glycosides, acyl glucamides, and mixtures thereof. Non-limiting examples of alkyl glucosides may include decyl glucoside, cocoyl glucoside, lauroyl glucoside, and combinations thereof.
[0043] Non-limiting examples of acyl glucamides include lauroyl / myristoyl methyl glucamide, capryloyl / caproyl methyl glucamide, lauroyl / myristoyl methyl glucamide, cocoyl methyl glucamide, and combinations thereof.
[0044] The composition may contain a non-ionic detersive surfactant which may include cocamide, cocamide methyl MEA, cocamide DEA, cocamide MEA, cocamide MIPA, lauramide DEA, lauramide MEA, lauramide MIPA, myristamide DEA, myristamide MEA, PEG-20 cocamide MEA, PEG-2 cocamide, PEG-3 cocamide, PEG-4 cocamide, PEG-5 cocamide, PEG-6 cocamide, PEG-7 cocamide, PEG-3 lauramide, PEG-5 lauramide, PEG-3 oleamide, PPG-2 cocamide, PPG-2 hydroxyethyl cocamide, and mixtures thereof.
[0045] B. Cationic polymers The cleansing composition may include cationic polymers that allow the formation of coacervates.As can be understood, the cationic charge of cationic polymers may interact with the anionic charge of surfactants to form coacervates.Suitable cationic polymers may include (a) cationic guar polymers, (b) cationic non-guar galactomannan polymers, (c) cationic starch polymers, (d) cationic copolymers of acrylamide monomers and cationic monomers, (e) synthetic non-crosslinked cationic polymers that may or may not form lyotropic liquid crystals when combined with detergent surfactants, and (f) cationic cellulose polymers.In certain examples, two or more cationic polymers may be included.
[0046] The cationic polymer may be present at about 0.05% to about 3% by weight, about 0.075% to about 2.0% by weight, or about 0.1% to about 1.0% by weight of the cleansing composition. The cationic polymer may have a cationic charge density of about 0.2 meq / g to about 2.2 meq / g, about 0.3 meq / g to about 2.0 meq / g, about 0.4 meq / g to about 1.8 meq / g; about 0.5 meq / g to about 1.7 meq / g, and about 0.6 meq / g to about 1.3. The charge density may be measured at the pH of the intended use of the cleansing composition. (e.g., about pH 3 to about pH 9, or about pH 4 to about pH 8). The average molecular weight of the cationic polymer can generally be about 10,000 to about 10,000,000, about 50,000 to about 5,000,000, and about 100,000 to about 3,000,000, and about 300,000 to about 3,000,000, and about 100,000 to about 2,500,000. A low molecular weight cationic polymer can be used. A low molecular weight cationic polymer can have a higher translucency in the liquid carrier of the cleansing composition. The cationic polymer can be a single type, such as guar hydroxypropyltrimonium chloride, a cationic guar polymer having a weight average molecular weight of about 2,500,000 g / mol or less, and the cleansing composition can have additional cationic polymers of the same or different types.
[0047] Cationic Guar Polymer The cationic polymer may be a cationic guar polymer, which is a cationic substituted galactomannan (guar) gum derivative. The guar gum suitable for the guar gum derivative may be obtained as a naturally occurring material from the seeds of the guar plant. As can be understood, the guar molecule is a linear mannan with regular intervals of branching single-membered galactose units on alternating mannose units. The mannose units are linked together by β(1-4) glycosidic bonds. The galactose branches arise by α(1-6) bonds. The cationic derivative of guar gum may be obtained through the reaction between the hydroxyl groups of the polygalactomannan and reactive quaternary ammonium compounds. The degree of substitution of cationic groups on the guar structure may be sufficient to provide the required cationic charge density as described above.
[0048] The cationic guar polymer can have a weight average molecular weight ("molecular weight") of less than about 3,000,000 g / mole and a charge density of about 0.05 meq / g to about 2.5 meq / g. Alternatively, the cationic guar polymer can have a weight average molecular weight of less than 1,500,000 g / mole, about 150,000 g / mole to about 1,500,000 g / mole, about 200,000 g / mole to about 1,500,000 g / mole, about 300,000 g / mole to about 1,500,000 g / mole, and about 700,000,000 g / mole to about 1,500,000 g / mole. The cationic guar polymers can have a charge density of from about 0.2 meq / g to about 2.2 meq / g, from about 0.3 meq / g to about 2.0 meq / g, from about 0.4 meq / g to about 1.8 meq / g; from about 0.5 meq / g to about 1.7 meq / g, and from about 0.6 meq / g to about 1.3.
[0049] The cationic guar polymer can have a weight average molecular weight of less than about 1,000,000 g / mole and can have a charge density of from about 0.1 meq / g to about 2.5 meq / g. The cationic guar polymer can have a weight average molecular weight of less than 900,000 g / mol, from about 150,000 to about 800,000 g / mol, from about 200,000 g / mol to about 700,000 g / mol, from about 300,000 to about 700,000 g / mol, from about 400,000 to about 600,000 g / mol, from about 150,000 g / mol to about 800,000 g / mol, from about 200,000 g / mol to about 700,000 g / mol, from about 300,000 g / mol to about 700,000 g / mol, and from about 400,000 g / mol to about 600,000 g / mol. The cationic guar polymers have a charge density of from about 0.2 meq / g to about 2.2 meq / g, from about 0.3 meq / g to about 2.0 meq / g, from about 0.4 meq / g to about 1.8 meq / g, and from about 0.5 meq / g to about 1.5 meq / g.
[0050] The cleansing composition may comprise from about 0.01% to less than about 0.7%, from about 0.04% to about 0.55%, from about 0.08% to about 0.5%, from about 0.16% to about 0.5%, from about 0.2% to about 0.5%, from about 0.3% to about 0.5%, and from about 0.4% to about 0.5% by weight of the cleansing composition of cationic guar polymer.
[0051] Cationic guar polymers may be formed from quaternary ammonium compounds conforming to the following general formula II:
[0052] [ka] In the formula, R 3 , R 4 , and R 5 is a methyl group or an ethyl group, R 6 is an epoxyalkyl group of the general formula III:
[0053] [ka] Or R 6 is a halohydrin group of general formula IV:
[0054] [ka] In the formula, R 7 is a C1-C3 alkylene, X is chlorine or bromine, and Z is an anion such as Cl-, Br-, I-, or HSO4-.
[0055] Suitable cationic guar polymers may conform to the following general formula V:
[0056] [ka] In the formula, R 8 is guar gum, R 4 , R 5 , R 6 , and R 7 is as defined above and Z is a halogen. Suitable cationic guar polymers may conform to the following formula VI:
[0057] [ka] In the formula, R 8 is guar gum.
[0058] Suitable cationic guar polymers may also include cationic guar gum derivatives such as guar hydroxypropyltrimonium chloride. Suitable examples of guar hydroxypropyltrimonium chloride may include Jaguar series available from Solvay SA, Hi-Care series available from Rhodia, and N-Hance and AquaCat available from Ashland Inc. Jaguar C-500 has a charge density of 0.8 meq / g and a molecular weight of 500,000 g / mole; Optima has a cationic charge density of about 1.25 meq / g and a molecular weight of about 500,000 g / mole, Jaguar® C-17 has a cationic charge density of about 0.6 meq / g and a molecular weight of about 2,200,000 g / mole, Jaguar® and a cationic charge density of about 0.8 meq / g, Hi-Care 1000 has a charge density of about 0.7 meq / g and a molecular weight of about 600,000 g / mole, N-Hance 3269 and N-Hance 3270 have a charge density of about 0.7 meq / g and a molecular weight of about 425,000 g / mole, N-Hance 3196 has a charge density of about 0.8 meq / g and a molecular weight of about 1,100,000 g / mole, and AquaCat CG518 has a charge density of about 0.9 meq / g and a molecular weight of about 50,000 g / mol. N-Hance BF-13 and N-Hance BF-17 are borate (boron) free guar polymers. N-Hance BF-13 has a charge density of about 1.1 meq / g and a molecular weight of about 800,000, and N-Hance BF-17 has a charge density of about 1.7 meq / g and a molecular weight of about 800,000. BF-17 has a charge density of about 1.7 meq / g and a molecular weight of about 800,000. BF-17 has a charge density of about 1.7 meq / g and a molecular weight of about 800,000. BF-17 has a charge density of about 1.7 meq / g and a molecular weight of about 800,000. BF-17 has a charge density of about 1.7 meq / g and a molecular weight of about 800,000.
[0059] Cationic Non-Guar Galactomannan Polymers The cationic polymer may be a galactomannan polymer derivative. A suitable galactomannan polymer may have a mannose to galactose ratio of greater than 2:1 on a monomer to monomer basis and may be a cationic galactomannan polymer derivative or an amphoteric galactomannan polymer derivative with a net positive charge. As used herein, the term "cationic galactomannan" refers to a galactomannan polymer with cationic groups added. The term "amphoteric galactomannan" refers to a galactomannan polymer with cationic and anionic groups added such that the polymer has a net positive charge.
[0060] Galactomannan polymers may be present in the endosperm of legume seeds. Galactomannan polymers are composed of a combination of mannose and galactose monomers. Galactomannan molecules are linear mannans with regular intervals of branching of single-membered galactose units on specific mannose units. The mannose units are linked together by β(1-4) glycosidic bonds. The galactose branches occur by α(1-6) bonds. The ratio of mannose monomers to galactose monomers varies from plant species to plant species and may also be influenced by climate. Non-guar galactomannan polymer derivatives may have a mannose to galactose ratio of greater than 2:1 on a monomer to monomer basis. Suitable ratios of mannose to galactose may also be greater than 3:1, or greater than 4:1. Analysis of mannose to galactose ratios is well known in the art and is typically based on measuring galactose content.
[0061] Gums used in the preparation of non-guar galactomannan polymer derivatives may be obtained from naturally occurring materials such as plant seeds or beans. Examples of various non-guar galactomannan polymers include tara gum (3 parts mannose / 1 part galactose), carob or lob (4 parts mannose / 1 part galactose), and cassia gum (5 parts mannose / 1 part galactose).
[0062] The non-guar galactomannan polymer derivatives can have a molecular weight of from about 1,000 g / mole to about 10,000,000 g / mole, and a molecular weight of from about 5,000 g / mole to about 3,000,000 g / mole.
[0063] The cleansing compositions described herein may include a galactomannan polymer derivative having a cationic charge density of about 0.5 meq / g to about 7 meq / g. The galactomannan polymer derivative may have a cationic charge density of about 1 meq / g to about 5 meq / g. The degree of substitution of cationic groups onto the galactomannan structure may be sufficient to provide the required cationic charge density.
[0064] The galactomannan polymer derivatives may be cationic derivatives of non-guar galactomannan polymers, obtained by reaction of the hydroxyl groups of the polygalactomannan polymer with a reactive quaternary ammonium compound. Suitable quaternary ammonium compounds for use in forming the cationic galactomannan polymer derivatives include those conforming to general formulas II-VI, as defined above.
[0065] The cationic non-guar galactomannan polymer derivatives formed from the above-described reagents may be represented by the following general formula VII:
[0066] [ka] wherein R is a gum. The cationic galactomannan derivative may be gum hydroxypropyltrimethylammonium chloride, which may be more specifically represented by the following general formula VIII:
[0067] [ka]
[0068] The galactomannan polymer derivative can be an amphoteric galactomannan polymer derivative having a net positive charge, which is obtained when the cationic galactomannan polymer derivative further comprises an anionic group.
[0069] Cationic non-guar galactose ratios can have a mannose to galactose ratio of greater than about 4:1, a molecular weight of about 100,000 g / mole to about 500,000 g / mole, a molecular weight of about 50,000 g / mole to about 400,000 g / mole, and a cationic charge density of about 1 meq / g to about 5 meq / g, and about 2 meq / g to about 4 meq / g.
[0070] The cleansing composition may comprise at least about 0.05% of the galactomannan polymer derivative by weight of the composition.The cleansing composition may comprise from about 0.05% to about 2% of the galactomannan polymer derivative by weight of the composition.
[0071] Cationic Starch Polymers Suitable cationic polymers may also be water-soluble cationically modified starch polymers. As used herein, the term "cationically modified starch" refers to starch to which cationic groups have been added before the starch is degraded to a smaller molecular weight, or to starch to which cationic groups have been added after the starch has been modified to reach a desired molecular weight. The definition of the term "cationically modified starch" also includes amphoterically modified starch. The term "amphoterically modified starch" refers to starch hydrolysates to which cationic and anionic groups have been added.
[0072] The cleansing compositions described herein may contain cationic modified starch polymers in the range of about 0.01% to about 10%, and / or about 0.05% to about 5%, by weight of the composition.
[0073] The cationically modified starch polymers disclosed herein have a percentage of bound nitrogen from about 0.5% to about 4%.
[0074] The cationically modified starch polymers can have a molecular weight of from about 850,000 g / mole to about 15,000,000 g / mole, and from about 900,000 g / mole to about 5,000,000 g / mole.
[0075] Cationic modified starch polymers may have a charge density of about 0.2 meq / g to about 5 meq / g, and about 0.2 meq / g to about 2 meq / g. Chemical modifications to obtain such charge densities may include the addition of amino and / or ammonium groups to the starch molecule. Non-limiting examples of such ammonium groups may include substituents such as hydroxypropyltrimonium chloride, trimethylhydroxypropylammonium chloride, dimethylstearylhydroxypropylammonium chloride, and dimethyldodecylhydroxypropylammonium chloride. Further details are provided in Solarek, DB, Cationic Starches in Modified Starches: Properties and Uses, Wurzburg, OB, Ed., CRC Press, Inc., Boca Raton, Fla. 1986, pp 113-125, which is incorporated herein by reference. Cationic groups may be added to the starch before it is broken down to smaller molecular weights, or cationic groups may be added after such modification.
[0076] The cationically modified starch polymer may have a degree of substitution of cationic groups of from about 0.2 to about 2.5. As used herein, the "degree of substitution" of a cationically modified starch polymer is the average number of hydroxyl groups on each anhydroglucose unit that are derivatized with a substituent. Since each anhydroglucose unit has three possible hydroxyl groups available for substitution, the maximum degree of substitution possible is three. The degree of substitution is expressed on a molar average basis as the number of moles of substituents per mole of anhydroglucose unit. The degree of substitution can be determined by proton nuclear magnetic resonance spectroscopy ("NMR") as is well known in the art. 1 The molecular weight can be determined using 1 H NMR ("H NMR") techniques. 1Examples of H NMR methods include those described in "Observation on NMR Spectra of Starches in Dimethyl Sulfoxide, Iodine-Complexing, and Solvating in Water-Dimethyl Sulfoxide", Qin-Ji Peng and Arthur S. Perlin, Carbohydrate Research, 160 (1987), 57-72, and "An Approach to the Structural Analysis of Oligosaccharides by NMR Spectroscopy", J. Howard Bradbury and J. Grant Collins, Carbohydrate Research, 71, (1979), 15-25.
[0077] The starch source before chemical modification can be selected from various sources such as tubers, legumes, cereals, and grains. For example, the starch source can include corn starch, wheat starch, rice starch, waxy corn starch, oat starch, cassava starch, waxy barley, waxy rice starch, glutenous rice starch, sweet rice starch, amioca, potato starch, tapioca starch, oat starch, sago starch, sweet rice, or mixtures thereof. Suitable cationically modified starch polymers can be selected from degraded cationic corn starch, cationic tapioca, cationic potato starch, and mixtures thereof. The cationically modified starch polymers are cationic corn starch and cationic tapioca.
[0078] Starch may include one or more additional modifications before or after degradation to smaller molecular weights. For example, these modifications may include crosslinking, stabilization reactions, phosphorylation, and hydrolysis. Stabilization reactions may include alkylation and esterification.
[0079] The cationically modified starch polymers may be included in the cleansing composition in the form of hydrolyzed starch (e.g., acid, enzymatic, or alkaline degradation), oxidized starch (e.g., peroxide, peracid, hypochlorite, alkali, or any other oxidizing agent), physically / mechanically degraded starch (e.g., by thermomechanical energy input of processing equipment), or combinations thereof.
[0080] Starch can be easily dissolved in water and can form a substantially translucent solution in water. The transparency of the composition is measured by Ultra-Violet / Visible (UV / VIS) spectrophotometry, which uses a Gretag Macbeth Colorimeter Color to measure the absorption or transmission of UV / VIS light of a sample. It has been shown that a light wavelength of 600 nm is suitable for characterizing the transparency of cleansing compositions.
[0081] Cationic copolymer of acrylamide monomer and cationic monomer The cleansing composition may include a cationic copolymer of acrylamide monomers and cationic monomers, the copolymer having a charge density of about 1.0 meq / g to about 3.0 meq / g. The cationic copolymer may be a synthetic cationic copolymer of acrylamide monomers and cationic monomers.
[0082] Suitable cationic polymers may include: (i) an acrylamide monomer of formula IX:
[0083] [ka] In the formula, R 9 is H or C 1~4 is alkyl, R 10 and R 11 are independently H, C 1~4 alkyl, CH2OCH3, CH2OCH2CH(CH3)2, and phenyl, or together selected from the group consisting of C3~6 It is cycloalkyl. (ii) a cationic monomer conforming to formula X:
[0084] [ka] wherein k=1, v, v', and v'' are each independently an integer from 1 to 6, w is zero or an integer from 1 to 10, and X - is an anion.
[0085] The cationic monomer may conform to the formula X, where k=1, v=3, and w=0, z=1; - is Cl - which forms the following structure (Formula XI):
[0086] [ka] As can be appreciated, the above structure can be referred to as a diquat.
[0087] The cationic monomer may conform to the formula X, where v and v″ are each 3, v′=1, w=1, y=1, and X - is Cl - which forms a structure of formula XII:
[0088] [ka] The structure of formula XII can be referred to as a triquat.
[0089] The acrylamide monomer can be either acrylamide or methacrylamide.
[0090] The cationic copolymer can be AM:TRIQUAT, which is a copolymer of acrylamide and 1,3-propanediaminium, N-[2-[[[dimethyl[3-[(2-methyl-1-oxo-2-propenyl)amino]propyl]ammonio]acetyl]amino]ethyl]2-hydroxy-N,N,N',N',N'-pentamethyl-, trichloride. AM:TRIQUAT is also known as polyquaternium 76 (PQ76). AM:TRIQUAT can have a charge density of 1.6 meq / g and a molecular weight of 1,100,000 g / mole.
[0091] The cationic copolymer may comprise an acrylamide monomer and a cationic monomer selected from the group consisting of dimethylaminoethyl (meth)acrylate, dimethylaminopropyl (meth)acrylate, ditertiobutylaminoethyl (meth)acrylate, dimethylaminomethyl (meth)acrylamide, dimethylaminopropyl (meth)acrylamide; ethyleneimine, vinylamine, 2-vinylpyridine, 4-vinylpyridine; trimethylammoniumethyl (meth)acrylate chloride, trimethylammoniumethyl (meth)acrylate methylsulfate, dimethylammoniumethyl (meth)acrylate benzyl chloride, 4-benzoylbenzyldimethylammoniumethyl acrylate chloride, trimethylammoniumethyl (meth)acrylamido chloride, trimethylammoniumpropyl (meth)acrylamido chloride, vinylbenzyltrimethylammonium chloride, diallyldimethylammonium chloride, and mixtures thereof.
[0092] The cationic copolymer may comprise a cationic monomer selected from the group consisting of trimethylammonium ethyl (meth)acrylate chloride, trimethylammonium ethyl (meth)acrylate methyl sulfate, dimethylammonium ethyl (meth)acrylate benzyl chloride, 4-benzoylbenzyl dimethylammonium ethyl acrylate chloride, trimethylammonium ethyl (meth)acrylamide chloride, trimethylammonium propyl (meth)acrylamide chloride, vinylbenzyl trimethylammonium chloride, and mixtures thereof.
[0093] The cationic copolymer may be formed from (1) a copolymer of (meth)acrylamide, a cationic monomer based on (meth)acrylamide, and / or a cationic monomer that is stable against hydrolysis, and (2) a terpolymer of (meth)acrylamide, a monomer based on a cationic (meth)acrylic acid ester, a monomer based on (meth)acrylamide, and / or a cationic monomer that is stable against hydrolysis. The monomer based on a cationic (meth)acrylic acid ester may be a cationic ester of (meth)acrylic acid containing a quaternized nitrogen atom. The cationic ester of (meth)acrylic acid containing a quaternized nitrogen atom may be a dialkylaminoalkyl (meth)acrylate quaternized at C1-C3 in the alkyl and alkylene groups. The cationized ester of (meth)acrylic acid containing a quaternized nitrogen atom may be selected from the group consisting of dimethylaminomethyl (meth)acrylate, dimethylaminoethyl (meth)acrylate, dimethylaminopropyl (meth)acrylate, diethylaminomethyl (meth)acrylate, diethylaminoethyl (meth)acrylate, and diethylaminopropyl (meth)acrylate ammonium salts quaternized with methyl chloride. The cationized ester of (meth)acrylic acid containing a quaternized nitrogen atom may be dimethylaminoethyl acrylate quaternized with an alkyl halide, or with methyl chloride or benzyl chloride or dimethyl sulfate (ADAME-Quat). When the cationic monomer is based on (meth)acrylamide, it is a dialkylaminoalkyl (meth)acrylamide quaternized at C1-C3 in the alkyl and alkylene groups, or a dimethylaminopropyl acrylamide quaternized with an alkyl halide, or with methyl chloride or benzyl chloride or dimethyl sulfate.
[0094] The (meth)acrylamide-based cationic monomer may be a dialkylaminoalkyl(meth)acrylamide quaternized with C1-C3 in the alkyl and alkylene groups. The (meth)acrylamide-based cationic monomer may be a dimethylaminopropylacrylamide quaternized with an alkyl halide, in particular with methyl chloride or benzyl chloride or dimethyl sulfate.
[0095] The cationic monomer may be a hydrolytically stable cationic monomer. In addition to dialkylaminoalkyl(meth)acrylamide, the hydrolytically stable cationic monomer may be any monomer that may be considered stable to the OECD hydrolysis test. The cationic monomer may be hydrolytically stable, and the hydrolytically stable cationic monomer may be selected from the group consisting of diallyldimethylammonium chloride and water-soluble cationic styrene derivatives.
[0096] The cationic copolymer can be a terpolymer of acrylamide, 2-dimethylammoniumethyl(meth)acrylate quaternized with methyl chloride (ADAME-Q), and 3-dimethylammoniumpropyl(meth)acrylamide quaternized with methyl chloride (DIMAPA-Q). The cationic copolymer can be formed from acrylamide and acrylamidopropyltrimethylammonium chloride, which has a charge density of about 1.0 meq / g to about 3.0 meq / g.
[0097] The cationic copolymer can have a charge density of from about 1.1 meq / g to about 2.5 meq / g, from about 1.1 meq / g to about 2.3 meq / g, from about 1.2 meq / g to about 2.2 meq / g, from about 1.2 meq / g to about 2.1 meq / g, from about 1.3 meq / g to about 2.0 meq / g, and from about 1.3 meq / g to about 1.9 meq / g.
[0098] The cationic copolymer can have a molecular weight of about 100,000 g / mol to about 2,000,000 g / mol, about 300,000 g / mol to about 1,800,000 g / mol, about 500,000 g / mol to about 1,600,000 g / mol, about 700,000 g / mol to about 1,400,000 g / mol, and about 900,000 g / mol to about 1,200,000 g / mol.
[0099] The cationic copolymer can be trimethylammoniopropyl methacrylamide chloride-N-acrylamide copolymer, also known as AM:MAPTAC. AM:MAPTAC can have a charge density of about 1.3 meq / g and a molecular weight of about 1,100,000 g / mole. The cationic copolymer can be AM:ATPAC. AM:ATPAC can have a charge density of about 1.8 meq / g and a molecular weight of about 1,100,000 g / mole.
[0100] Synthetic Polymers The cationic polymer is i) one or more cationic monomer units, and optionally ii) one or more monomeric units that have a negative charge; and / or iii) non-ionic monomers, Here, the subsequent charge of the copolymer is positive. The ratio of these three monomers is represented by "m", "p" and "q", where "m" is the number of cationic monomers, "p" is the number of monomers carrying a negative charge and "q" is the number of non-ionic monomers.
[0101] The cationic polymer may be a water-soluble or dispersible, non-crosslinked synthetic cationic polymer having the structure of Formula XIII:
[0102] [ka] wherein A may be one or more of the following cationic moieties:
[0103] [ka] where @ is an amide, alkylamide, ester, ether, alkyl, or alkylaryl; In the formula, Y is a C1 to C22 alkyl, alkoxy, alkylidene, alkyl, or aryloxy; In the formula, ψ is C1 to C22 alkyl, alkyloxy, alkylaryl, or alkylaryloxy. In the formula, Z is C1 to C22 alkyl, alkyloxy, aryl, or aryloxy; In the formula, R1 is H, C1-C4 linear or branched alkyl, wherein s is 0 or 1, and n is 0 or ≧1; In the formula, T and R7 are C1 to C22 alkyl. X- is a halogen, hydroxide, alkoxide, sulfate or alkyl sulfate.
[0104] In the above structure, the negatively charged monomer is defined by R2' being H, C1-C4 straight or branched alkyl, and R3 being:
[0105] [ka] wherein D is O, N, or S; In the formula, Q is NH2 or O; In the formula, u is 1 to 6. In the formula, t is 0 to 1, where J is an oxygenated functional group containing the following elements P, S, C:
[0106] In the above structure, the nonionic monomer is R2″ is H, C1-C4 linear or branched alkyl, R6 is linear or branched alkyl, alkylaryl, aryloxy, alkyloxy, alkylaryloxy, and β is
[0107] [ka] (wherein G′ and G″ are independently O, S, or NH; and L is 0 or 1).
[0108] Suitable monomers may include aminoalkyl (meth)acrylates, (meth)aminoalkyl (meth)acrylamides; monomers containing at least one secondary, tertiary, or quaternary amine functional group, or a heterocyclic group containing a nitrogen atom, vinylamine or ethyleneimine; diallyldialkylammonium salts; mixtures thereof, salts thereof, and macromonomers derived therefrom.
[0109] Further examples of suitable cationic monomers may include dimethylaminoethyl (meth)acrylate, dimethylaminopropyl (meth)acrylate, ditertiobutylaminoethyl (meth)acrylate, dimethylaminomethyl (meth)acrylamide, dimethylaminopropyl (meth)acrylamide, ethylenimine, vinylamine, 2-vinylpyridine, 4-vinylpyridine, trimethylammoniumethyl (meth)acrylate chloride, trimethylammoniumethyl (meth)acrylate methylsulfate, dimethylammoniumethyl (meth)acrylate benzyl chloride, 4-benzoylbenzyldimethylammoniumethyl acrylate chloride, trimethylammoniumethyl (meth)acrylamido chloride, trimethylammoniumpropyl (meth)acrylamido chloride, vinylbenzyltrimethylammonium chloride, diallyldimethylammonium chloride.
[0110] Suitable cationic monomers include those of the formula -NR3 +where each R may be the same or different and may be a hydrogen atom, an alkyl group containing 1 to 10 carbon atoms, or a benzyl group, optionally having a hydroxyl group, and including an anion (counterion). Examples of suitable anions include halides such as chloride, bromide, sulfate, hydrosulfate, alkyl sulfates (e.g., containing 1 to 6 carbon atoms), phosphate, citrate, formate, and acetate.
[0111] Suitable cationic monomers may also include trimethylammonium ethyl (meth)acrylate chloride, trimethylammonium ethyl (meth)acrylate methyl sulfate, dimethylammonium ethyl (meth)acrylate benzyl chloride, 4-benzoylbenzyl dimethylammonium ethyl acrylate chloride, trimethylammonium ethyl (meth)acrylamide chloride, trimethylammonium propyl (meth)acrylamide chloride, vinylbenzyl trimethylammonium chloride. Additional suitable cationic monomers may include trimethylammonium propyl (meth)acrylamide chloride.
[0112] Examples of negatively charged monomers include alpha ethylenically unsaturated monomers containing phosphate or phosphonate groups, alpha ethylenically unsaturated monocarboxylic acids, monoalkyl esters of alpha ethylenically unsaturated dicarboxylic acids, monoalkyl amides of alpha ethylenically unsaturated dicarboxylic acids, alpha ethylenically unsaturated compounds containing sulfonic acid groups, and salts of alpha ethylenically unsaturated compounds containing sulfonic acid groups.
[0113] Suitable monomers having a negative charge may include acrylic acid, methacrylic acid, vinyl sulfonic acid, salts of vinyl sulfonic acid, vinylbenzene sulfonic acid, salts of vinylbenzene sulfonic acid, alpha-acrylamidomethylpropanesulfonic acid, salts of alpha-acrylamidomethylpropanesulfonic acid, 2-sulfoethyl methacrylate, salts of 2-sulfoethyl methacrylate, acrylamido-2-methylpropanesulphonic acid (AMPS), salts of acrylamido-2-methylpropanesulphonic acid, and styrenesulphonate (SS).
[0114] Examples of non-ionic monomers may include vinyl acetate, amides of alpha ethylenically unsaturated carboxylic acids, esters of alpha ethylenically unsaturated monocarboxylic acids with hydrogenated or fluorinated alcohols, polyethylene oxide (meth)acrylates (i.e., polyethoxylated (meth)acrylic acids), mono alkyl esters of alpha ethylenically unsaturated dicarboxylic acids, mono alkyl amides of alpha ethylenically unsaturated dicarboxylic acids, vinyl nitriles, vinyl amine amides, vinyl alcohol, vinyl pyrrolidone, and vinyl aromatic compounds.
[0115] Suitable nonionic monomers may also include styrene, acrylamide, methacrylamide, acrylonitrile, methyl acrylate, ethyl acrylate, n-propyl acrylate, n-butyl acrylate, methyl methacrylate, ethyl methacrylate, n-propyl methacrylate, n-butyl methacrylate, 2-ethyl-hexyl acrylate, 2-ethyl-hexyl methacrylate, 2-hydroxyethyl acrylate, and 2-hydroxyethyl methacrylate.
[0116] Anionic counterions (X) associated with synthetic cationic polymers -) can be any known counterion so long as the polymer remains soluble or dispersible in water, the cleansing composition, or a coacervate phase of the cleansing composition, and so long as the counterion is physically and chemically compatible with the essential components of the cleansing composition or does not otherwise unduly impair product performance, stability, or aesthetics. Non-limiting examples of suitable counterions can include halides (e.g., chlorine, fluorine, bromine, iodine), sulfate, and methylsulfate.
[0117] The cationic polymers described herein may also help repair damaged hair, especially chemically treated hair, by providing a substitute hydrophobic F-layer. The microscopically thin F-layer helps seal in moisture and prevents further damage while providing natural weather resistance. Chemical treatment damages the hair cuticle, causing the protective F-layer to peel off from the hair. As the F-layer peels off, the hair becomes more hydrophilic. It has been found that application of lyotropic liquid crystals to chemically treated hair makes the hair more hydrophobic, and makes it look and feel like untreated hair. Without being bound by any theory, it is believed that the lyotropic liquid crystal complex forms a hydrophobic layer or film that coats the hair fiber and protects the hair in the same way that a natural F-layer protects the hair. The hydrophobic layer may restore the hair to a healthier state, typically like untreated hair. Lyotropic liquid crystals are formed by combining the synthetic cationic polymers described herein with the anionic detergent surfactant component of the above-mentioned cleansing composition.The charge density of synthetic cationic polymers is relatively high.It should be noted that some synthetic polymers with relatively high cationic charge density do not form lyotropic liquid crystals, mainly due to their unusual linear charge density.Such synthetic cationic polymers are described in PCT Patent Application No. 94 / 06403, which is incorporated by reference.The synthetic polymers described herein can be formulated into a stable cleansing composition that provides improved conditioning performance for damaged hair.
[0118] The cationic synthetic polymer capable of forming lyotropic liquid crystal has a cationic charge density of about 2 meq / gm to about 7 meq / gm, and / or about 3 meq / gm to about 7 meq / gm, and / or about 4 meq / gm to about 7 meq / gm. The cationic charge density is about 6.2 meq / gm. The polymer also has a molecular weight of about 1,000 to about 5,000,000, and / or about 10,000 to about 2,000,000, and / or about 100,000 to about 2,000,000.
[0119] Cationic synthetic polymers that provide enhanced conditioning and deposition of benefit agents, but do not necessarily form lyotropic liquid crystals, may have a cationic charge density of from about 0.7 meq / gm to about 7 meq / gm, and / or from about 0.8 meq / gm to about 5 meq / gm, and / or from about 1.0 meq / gm to about 3 meq / gm. The polymers also have molecular weights of from about 1,000 g / mole to about 5,000,000 g / mole, from about 10,000 g / mole to about 2,000,000 g / mole, and from about 100,000 g / mole to about 2,000,000 g / mole.
[0120] Cationic Cellulose Polymer A suitable cationic polymer may be a cellulose polymer. The cationic cellulose polymer may have a cationic charge density of about 0.2 meq / g to about 2.2 meq / g, about 0.3 meq / g to about 2.0 meq / g, about 0.4 meq / g to about 1.8 meq / g; about 0.5 meq / g to about 1.7 meq / g, and about 0.6 meq / g to about 1.3. A suitable cellulose polymer may include a salt of hydroxyethyl cellulose reacted with trimethylammonium-substituted epoxide, referred to in the industry (CTFA) as Polyquaternium 10, available from Dow / Amerchol Corp. (Edison, NJ, USA) as Polymer LR, JR, and KG series polymers. Another suitable type of cationic cellulose may include a polymeric quaternary ammonium salt of hydroxyethyl cellulose reacted with lauryldimethylammonium-substituted epoxide, referred to in the industry (CTFA) as Polyquaternium 24. These materials are available from Dow / Amerchol Corp. under the trade name Polymer LM-200. Other suitable types of cationic cellulose may include polymeric quaternary ammonium salts of hydroxyethylcellulose reacted with lauryldimethylammonium- and trimethylammonium-substituted epoxides, referred to in the industry (CTFA) as Polyquaternium 67. These materials are available from Dow / Amerchol Corp. under the trade names SoftCAT Polymer SL-5, SoftCAT Polymer SL-30, Polymer SL-60, Polymer SL-100, Polymer SK-L, Polymer SK-M, Polymer SK-MH, and Polymer SK-H.
[0121] Additional cationic polymers are also described in the CTFA Cosmetic Ingredient Dictionary, 3rd edition, edited by Estrin, Crosley, and Haynes (The Cosmetic, Toiletry, and Fragrance Association, Inc. (Washington, DC) (1982)), which is incorporated herein by reference.
[0122] Techniques for analyzing the formation of complex coacervates are known in the art. For example, microscopic analysis of the composition at any selected dilution stage can be used to identify whether a coacervate phase has formed. Such a coacervate phase may be identifiable as an additional emulsified phase in the composition. The use of dyes may help distinguish the coacervate phase from other insoluble phases dispersed in the composition. Further details regarding the use of cationic polymers and coacervates are disclosed in U.S. Patent No. 9,272,164, which is incorporated herein by reference.
[0123] C. Stabilizing Polymers The personal cleansing composition may include a stabilizing polymer to increase the viscosity or yield stress of the composition. A suitable stabilizing polymer may be used in the personal cleansing composition, and the personal cleansing composition may include about 0.05% to 10% of the stabilizing polymer; 0.1% to about 9% of the stabilizing polymer, about 0.4% to about 8% of the stabilizing polymer, about 0.7% to about 5% of the stabilizing modified polymer, and about 1% to about 2.5% of the stabilizing polymer. The stabilizing polymer modifier may be a polyacrylate, a polyacrylamide thickener. The stabilizing polymer may be an anionic stabilizing polymer.
[0124] The personal cleansing composition may include a stabilizing polymer that is a homopolymer based on acrylic acid, methacrylic acid, or other related derivatives, non-limiting examples include polyacrylates, polymethacrylates, polyethylacrylates, and polyacrylamides.
[0125] The stabilizing polymers may be alkali-swellable and hydrophobically modified alkali-swellable acrylic or methacrylate copolymers, non-limiting examples of which include acrylic acid / acrylonitrile copolymer, acrylates / steareth-20 itaconate copolymer, acrylates / ceteth-20 itaconate copolymer, acrylates / aminoacrylate / C10-30 alkyl PEG-20 itaconate copolymer, acrylates / aminoacrylate copolymer, acrylates / steareth-20 methacrylate copolymer, a Acrylates / Beheneth-25 Methacrylate Copolymer, Acrylates / Steareth-20 Methacrylate Crosspolymer, Acrylates / Beheneth-25 Methacrylate / HEMA Crosspolymer, Acrylates / Vinyl Neodecanoate Crosspolymer, Acrylates / Vinyl Isodecanoate Crosspolymer, Acrylates / Palmeth-25 Acrylate Copolymer, Acrylic Acid / Acrylamidomethylpropanesulfonic Acid Copolymer, and Acrylates / C10-C30 Alkyl Acrylate Crosspolymer.
[0126] The stabilizing polymer may be a soluble crosslinked acrylic polymer, a non-limiting example of which is carbomer.
[0127] The stabilizing polymer may be an associative polymer thickener, non-limiting examples of which include hydrophobically modified alkali swellable emulsions, non-limiting examples of which include hydrophobically modified polyacrylates; hydrophobically modified polyacrylic acids, and hydrophobically modified polyacrylamides; hydrophobically modified polyethers, which may have a hydrophobicity selected from cetyl, stearyl, oleayl, and combinations thereof.
[0128] The stabilizing polymer may be used in combination with polyvinylpyrrolidone, crosslinked polyvinylpyrrolidone, and derivatives. The stabilizing polymer may be combined with polyvinyl alcohol and derivatives. The stabilizing polymer may be combined with polyethyleneimine and derivatives.
[0129] Stabilizing polymers may be combined with alginate-based materials, non-limiting examples of which include sodium alginate and propylene glycol alginate.
[0130] Stabilizing polymers can be used in combination with polyurethane polymers, non-limiting examples of which include hydrophobically modified alkoxylated urethane polymers, non-limiting examples of which include PEG-150 / decyl alcohol / SMDI copolymer, PEG-150 / stearyl alcohol / SMDI copolymer, polyurethane-39.
[0131] Stabilizing polymers may be combined with associative polymer thickeners, non-limiting examples include hydrophobically modified cellulose derivatives and hydrophilic moieties of repeating ethylene oxide groups with repeat units of 10 to 300, 30 to 200, and 40 to 150. Non-limiting examples of this category include PEG-120-methyl glucose dioleate, PEG-(40 or 60) sorbitan tetraoleate, PEG-150 pentaerythrityl tetrastearate, PEG-55 propylene glycol oleate, PEG-150 distearate.
[0132] The stabilizing polymer may be combined with cellulose and derivatives including cellulose gums, non-limiting examples of which include microcrystalline cellulose, carboxymethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropyl methyl cellulose, methyl cellulose, ethyl cellulose; nitrocellulose; cellulose sulfate; cellulose powder; hydrophobically modified cellulose.
[0133] The stabilizing polymer may be combined with guar and guar derivatives, non-limiting examples of which include hydroxypropyl guar, and hydroxypropyl guar hydroxypropyltrimonium chloride.
[0134] The stabilizing polymer may be combined with polyethylene oxide, polypropylene oxide, and POE-PPO copolymers.
[0135] The stabilizing polymer may be combined with a polyalkylene glycol characterized by the general formula:
[0136] [ka] where R is hydrogen, methyl, or a mixture thereof, preferably hydrogen, and n is an integer having an average of 2,000 to 180,000, or 7,000 to 90,000, or 7,000 to 45,000. Non-limiting examples of this category include PEG-7M, PEG-14M, PEG-23M, PEG-25M, PEG-45M, PEG-90M, or PEG-100M.
[0137] The stabilizing polymer may be combined with silica, non-limiting examples of which include fumed silica, precipitated silica, and silicone surface treated silica.
[0138] The stabilizing polymer may be combined with a water-swellable clay, non-limiting examples of which include laponite, bentonite, montmorillonite, smectite, and hectonite.
[0139] The stabilizing polymer may be combined with gums, non-limiting examples of which include xanthan gum, guar gum, hydroxyprolyl guar gum, gum arabic, tragacanth, galactan, carob gum, karaya gum, and locust bean gum.
[0140] The stabilizing polymers may be combined with dibenzylidene sorbitol, carrageenan, pectin, agar, quince seed (Cydonia oblonga Mill), starch (obtained from rice, corn, potato, wheat, etc.), starch derivatives (e.g., carboxymethyl starch, methylhydroxypropyl starch), algae extracts, dextran, succinoglucan, and prelan.
[0141] Non-limiting examples of stabilizing polymers include acrylamide / ammonium acrylate copolymer (and) polyisobutene (and) polysorbate 20; acrylamide / sodium acryloyldimethyltaurate copolymer / isohexadecane / polysorbate 80, ammonium acryloyldimethyltaurate / VP copolymer, sodium acrylate / sodium acryloyldimethyltaurate copolymer, acrylates copolymer, acrylates crosspolymer-4, acrylates crosspolymer-3, acrylates / beheneth-25 methacrylate copolymer, acrylates / C10-C30 alkyl acrylate crosspolymer, acrylates / steareth-20 itaconate copolymer, polysorbate 80 ... Ammonium triacrylate / isohexadecane / PEG-40 castor oil; carbomer, sodium carbomer, crosslinked polyvinylpyrrolidone (PVP), polyacrylamide / C13-14 isoparaffin / laureth-7, polyacrylate 13 / polyisobutene / polysorbate 20, polyacrylate crosspolymer-6, polyamide-3, polyquaternium-37 (and) hydrogenated polydecene (and) trideceth-6, acrylamide / sodium acryloyldimethyltaurate / acrylic acid copolymer, sodium acrylate / acryloyldimethyltaurate / dimethylacrylamide crosspolymer (and) isohexadecane (and) polysorbate 60, sodium polyacrylate.Exemplary commercially available stabilizing polymers include ACULYN™ 28, ACULYN™ 88, ACULYN™ 33, ACULYN™ 22, ACULYN™ Excel, Carbopol® Aqua SF-1, Carbopol® ETD 2020, Carbopol® Ultrez 20, Carbopol® Ultrez 21, Carbopol® Ultrez 10, Carbopol® Ultrez 30, Carbopol® 1342, Carbopol® Aqua SF-2 polymer, Sepigel™ 305, Simulgel™ 600, Sepimax Zen, Carbopol® SMART1000, Rheocare® TTA, Rheomer® SC-Plus, STRUCTURE® PLUS, Aristoflex® AVC, Stabylen® 30, and combinations thereof.
[0142] D. Suspension wax The suspending wax includes suitable stabilizers to increase yield stress and viscosity. Such materials may include mono- and / or diesters of alkylene glycols having the formula:
[0143] [ka] In the formula, R1 is a linear or branched C12 to C22 alkyl group, R is a linear or branched C2-C4 alkylene group; P is selected from H, C1-C4 alkyl, or -COR2, where R2 is C4-C22 alkyl, or can be C12-C22 alkyl; n=1 to 3.
[0144] In the present invention, the long chain fatty ester may have the above general structure, where R1 is a linear or branched C16 to C22 alkyl group, R is -CH2-CH2-, P is selected from H or -COR2, and R2 is a C4 to C22 alkyl or may be a C12 to C22 alkyl.
[0145] Typical examples are the mono- and / or diesters of fatty acids containing from about 6 to about 22, from about 12 to about 18 carbon atoms, such as caproic acid, caprylic acid, 2-ethylhexanoic acid, capric acid, lauric acid, isotridecanoic acid, myristic acid, palmitic acid, palmitoleic acid, stearic acid, isostearic acid, oleic acid, elaidic acid, petroselinic acid, linoleic acid, linolenic acid, arachic acid, gadoleic acid, behenic acid, erucic acid, and mixtures thereof, with ethylene glycol, propylene glycol, diethylene glycol, dipropylene glycol, triethylene glycol, or tetraethylene glycol.
[0146] In the present invention, ethylene glycol monostearate (EGMS) and / or ethylene glycol distearate (EGDS) and / or polyethylene glycol monostearate (PGMS) and / or polyethylene glycol distearate (PGDS) may be the suspending wax used in the composition. There are several commercial sources of these materials. For example, PEG6000MS® is available from Stepan and Empilan EGDS / A® is available from Albright & Wilson.
[0147] Traditionally, glyceride ester compounds can be used as structuring agents in personal cleansing compositions.For example, Thixcin® R is a trihydroxystearin, a commercially available hydrogenated castor oil produced by Elementis Specialty (New Jersey) and marketed as a stabilizing and structuring agent for personal cleansing compositions.Suitable glyceride esters for the personal cleansing compositions described herein can be selected from any crystalline glyceride ester that allows the formation of coacervate in the personal cleansing composition comprising suitable surfactant and cationic polymer.For example, suitable glyceride esters are hydrogenated castor oils (such as trihydroxystearin or dihydroxystearin).
[0148] Examples of additional crystalline glyceride esters may include substantially pure triglyceride of 12-hydroxystearic acid.12-hydroxystearic acid is the pure form of triglyceride of 12-hydroxy-9-cis-octadecenoic acid that is completely hydrogenated.As can be understood, many additional glyceride esters are possible.For example, changes in hydrogenation process and natural changes in castor oil may allow the production of additional suitable glyceride esters from castor oil.
[0149] Suitable glyceride esters can also be formed from a mixture of one or more glycerides. For example, a mixture of glycerides containing about 80% or more of castor oil by weight of the mixture can be suitable. Other suitable mixtures can include a mixture of only triglycerides, a mixture of diglycerides and triglycerides, a mixture of triglycerides, diglycerides, and monoglycerides in limited amounts, such as less than about 20% by weight of the mixture, or any mixture thereof containing no more than about 20% by weight of the mixture of the corresponding acid hydrolysis products of any of the glycerides. About 80% or more by weight of the mixture can be chemically identical to the glyceride of fully hydrogenated ricinoleic acid, i.e., the glyceride of 12-hydroxystearic acid. Hydrogenated castor oil can be modified so that in a given triglyceride, there are two 12-hydroxystearin moieties and one stearin moiety. Alternatively, partial hydrogenation can be used. However, poly(oxyalkylated) castor oil is not preferred because it has an unfavorable melting point.
[0150] Castor oil includes glycerides, particularly triglycerides, that contain C10-C22 alkyl or alkenyl moieties with hydroxy groups. Hydrogenation of castor oil produces hydrogenated castor oil by conversion of double bonds present in the starting oil as ricinoleyl moieties. These moieties are converted to ricinoleyl moieties, which are saturated hydroxyalkyl moieties, e.g., hydroxystearyl. Hydrogenated castor oil (HCO) herein may be selected from trihydroxystearin, dihydroxystearin, and mixtures thereof. HCO can be processed in any suitable starting form, including, but not limited to, selected from solids, melts, and mixtures thereof. Useful HCO can have the following properties: a melting point of about 40° C. to about 100° C., alternatively about 65° C. to about 95° C., and / or an iodine value ranging from about 0 to about 5, alternatively about 0 to about 4, alternatively about 0 to about 2.6. The melting point of HCO can be measured using DSC: Differential Scanning Calorimetry.
[0151] Suitable HCOs include those available commercially. Non-limiting examples of commercially available HCOs suitable for use include THIXCIN-R® (supplied by Elementis), which is supplied as a powder having small particles (99% by weight smaller than 44 μm).
[0152] The present invention is not intended to be limited to the use of hydrogenated castor oil. Any other suitable crystallizable glycerides may be used. In one example, the structurant is a nearly pure triglyceride of 12-hydroxystearic acid. This molecule represents the pure form of the triglyceride of 12-hydroxy-9-cis-octadecenoic acid, which is fully hydrogenated. In nature, the composition of castor oil may vary to some extent. Similarly, the method of hydrogenation may vary. Any other suitable equivalent material may be used, such as a mixture of triglycerides, of which at least about 80% by weight is derived from castor oil. Exemplary equivalent materials comprise primarily or consist of triglycerides; or comprise primarily or consist of mixtures of diglycerides and triglycerides; or comprise primarily or consist of mixtures of triglycerides and diglycerides and limited amounts of monoglycerides, e.g., less than about 20% by weight of the mixture of glycerides; or comprise primarily or consist of any of the foregoing glycerides and limited amounts, e.g., less than about 20% by weight of the corresponding acid hydrolysis products of any of the foregoing glycerides.
[0153] The stabilized premix contains from about 4% to about 30% of 100% active stabilizer by weight of the personal cleansing composition. In the present invention, the stabilized premix may contain from about 15% to about 25% stabilizer.
[0154] The suspended wax in the present invention may be from about 0.01% to about 4%, the suspended wax in the present invention may be from about 0.1% to about 3%, the suspended wax in the present invention may be from about 0.5% to about 2%, and the suspended wax in the present invention may be from about 0.3% to about 1.5%.
[0155] E. Scalp active ingredients The present invention may comprise scalp actives, which may be anti-dandruff actives.Anti-dandruff actives may be selected from the group consisting of pyridinethione salts, zinc carbonate, azoles such as ketoconazole, econazole, and elubiol, keratolytic agents such as selenium sulfide, particulate sulfur, salicylic acid, and mixtures thereof.Anti-dandruff particles may be pyridinethione salts.Such anti-dandruff particulates must be physically and chemically compatible with the components of the composition and must not unduly impair the stability, aesthetics, or performance of the product.
[0156] Concentrations of scalp active ingredients can range from about 0.1% to about 10%, from about 2% to about 5%, and from about 1% to about 2%.
[0157] Pyridinethione particles are suitable particulate anti-dandruff actives for use in the compositions of the present invention. The anti-dandruff actives may be 1-hydroxy-2-pyridinethione salts and are in particulate form. The concentration of pyridinethione anti-dandruff particles may range from about 0.01% to about 5%, or from about 0.1% to about 3%, or from about 1% to about 2% by weight of the composition. Pyridinethione salts may be formed from heavy metals such as zinc, tin, cadmium, magnesium, aluminum, and zirconium, and generally from zinc, typically the zinc salt of 1-hydroxy-2-pyridinethione (known as "zinc pyridinethione" or "zinc pyridinethione, ZPT", zinc pyrithione), usually in the form of platelet particles, 1-hydroxy-2-pyridinethione salts. 1-hydroxy-2-pyridinethione salts, which may be in the form of platelet particles, may have an average particle size of up to about 20 microns, or up to about 5 microns, or up to about 2.5 microns.Salts formed from other cations, such as sodium, may also be suitable.Pyridinethione anti-dandruff actives are described, for example, in U.S. Patent Nos. 2,809,971, 3,236,733, 3,753,196, 3,761,418, 4,345,080, 4,323,683, 4,379,753, and 4,470,982.
[0158] In addition to the antidandruff active ingredient selected from polyvalent metal salts of pyrithione, the composition may further comprise one or more antifungal and / or antibacterial active ingredients. The antibacterial active ingredient may be selected from the group consisting of coal tar, sulfur, charcoal, copper pyrithione, Whitfield's ointment, Castellani's paint, aluminum chloride, gentian violet, hydroxylpyridines, which may be selected from the group consisting of piroctone olamine, octopirox (piroctone olamine), ciclopirox olamine, rilopirox, MEA-hydroxyoctyloxypyridinone; strobilurins such as azoxystrobin, and metal chelators such as 1,10-phenanthroline, undecylenic acid and its metal salts, potassium permanganate, selenium sulfide, sodium thiosulfate, propylene glycol, bitter orange oil, urea The preparation may be griseofulvin, 8-hydroxyquinoline ciloquinol, thiobendazole, thiocarbamate, haloprogin, polyenes, hydroxypyridones, morpholines, benzylamines, allylamines (e.g., terbinafine), tea tree oil, clove leaf oil, coriander, palmarosa, berberine, thyme red, cinnamon oil, cinnamic aldehyde, citronellic acid, hinokitol, ichthyol pale, Sensiva SC-50, Elestab HP-100, azelaic acid, lyticase, iodopropynyl butylcarbamate (IPBC), isothiazarinones such as octylisothiazarinone, and azoles, and combinations thereof. The antibacterial agent may be selected from the group consisting of itraconazole, ketoconazole, selenium sulfide, coal tar, and mixtures thereof.
[0159] The azole antibacterial agent may be an imidazole selected from the group consisting of benzimidazole, benzothiazole, bifonazole, butaconazole nitrate, climbazole, clotrimazole, cloconazole, eberconazole, econazole, elubiol, fenticonazole, fluconazole, flutimazole, isoconazole, ketoconazole, lanoconazole, metronidazole, miconazole, neticonazole, omoconazole, oxiconazole nitrate, sertaconazole, sarconazole nitrate, tioconazole, thiazole, and mixtures thereof, or the azole antibacterial agent is a triazole selected from the group consisting of terconazole, itraconazole, and mixtures thereof. The azole antibacterial active ingredient, when present in the composition, is included in an amount of about 0.01% to about 5%, or about 0.1% to about 3%, or about 0.3% to about 2% by weight of the total weight of the composition. The azole antibacterial active ingredient may be ketoconazole. The only antibacterial active ingredient may be ketoconazole.
[0160] The present invention may also include combinations of antibacterial active ingredients, which may be selected from the group consisting of combinations of octopirox and zinc pyrithione, pine tar and sulfur, salicylic acid and zinc pyrithione, salicylic acid and elubiol, zinc pyrithione and elubiol, zinc pyrithione and climbazole, octopirox and climbazole, salicylic acid and octopirox, and mixtures thereof.
[0161] The composition may include an effective amount of the zinc-containing layered material, based on the total weight of the composition, from about 0.001% to about 10%, or from about 0.01% to about 7%, or from about 0.1% to about 5% of the zinc-containing layered material.
[0162] Zinc-containing layered materials may be those in which crystal growth occurs primarily in two dimensions. It is conventional to describe the layered structure not only as having all atoms incorporated into well-defined layers, but also as having ions or molecules between the layers, called gallery ions (AF Wells, "Structural Inorganic Chemistry," Clarendon Press, 1975). Zinc-containing layered materials (ZLMs) may incorporate zinc into the layers and / or may be a component of the gallery ions. The following classifications of ZLMs are representative of relatively common examples of general categories and are not intended to be limiting with respect to the broader range of materials that fit this definition.
[0163] Many ZLMs occur naturally as minerals. The ZLMs may be selected from the group consisting of hydrozinc earth (zinc carbonate hydroxide), zinc carbonate base, hydrozinc cuprite (zinc copper carbonate hydroxide), zinc malachite (zinc copper carbonate hydroxide), and mixtures thereof. Related minerals containing zinc may also be included in the composition. Natural ZLMs may also exist in which anionic layer species such as clay minerals (e.g., phyllosilicates) contain ion-exchanged zinc gallery ions. All of these natural materials may be obtained synthetically or may be formed in situ in the composition or during the production process.
[0164] Another common class of ZLMs, which are often, but not always, synthetic, are the layered double hydroxides. ZLMs have the formula [M 2+ 1-x M 3+ x (OH)2] x+ A m- x / m nH2O (wherein divalent ions (M 2+) may be a layered double hydroxide conforming to (Crepaldi, EL, Pava, PC, Tronto, J, Valim, JB J. Colloid Interfac. Sci. 2002, 248, 429-42), in which some or all of the cations are zinc ions.
[0165] Yet another class of ZLMs, called hydroxy double salts, can also be prepared (Morioka, H., Tagaya, H., Karasu, M, Kadokawa, J, Chiba, K Inorg. Chem. 1999, 38, 4211-6). ZLMs have the formula [M 2+ 1-x M 2+ 1+x (OH) 3(1-y) ] + A n- (1=3y) / n nH2O (wherein two metal ions (M 2+ ) may be the same or different, and may be a hydroxy double salt corresponding to ). When the metal ion is the same and is represented by zinc, the formula is simplified to [Zn 1+x (OH)2] 2x+ 2x A - ·nH2O. This latter formula represents materials such as zinc hydroxychloride and zinc hydroxynitrate (where x=0.4). ZLM can be zinc hydroxychloride and / or zinc hydroxynitrate. They also refer to zinc hydrates, which replace monovalent anions with divalent anions. These materials can also be formed in situ in the composition or during the production process.
[0166] The composition may include basic zinc carbonate. Commercial sources of basic zinc carbonate include basic zinc carbonate (Cater Chemicals: Bensenville, IL, USA), zinc carbonate (Shepherd Chemicals: Norwood, OH, USA), zinc carbonate (CPS Union Corp.: New York, NY, USA), zinc carbonate (Elementis Pigments: Durham, UK), and zinc carbonate AC (Bruggemann Chemical: Newtown Square, PA, USA). Basic zinc carbonate, sometimes commercially referred to as "zinc carbonate", "zinc carbonate base", or "zinc hydroxycarbonate", is a compound made from a material similar to natural hydrozincate. The ideal stoichiometry is represented by Zn5(OH)6(CO3)2, but the actual stoichiometric ratio may vary slightly and other impurities may be incorporated into the crystal lattice.
[0167] The composition may comprise a zinc-containing layered material and pyrithione or a polyvalent metal salt of pyrithione, wherein the ratio of zinc-containing layered material to pyrithione or a polyvalent metal salt of pyrithione is from about 5:100 to about 10:1, or from about 2:10 to about 5:1, or from about 1:2 to about 3:1.
[0168] F. Preservatives The preservative may include one or more preservatives. Each single preservative may be present in an amount of about 0.1% to about 2% by weight of the composition, about 0.3% to about 1.5% by weight of the composition, about 0.45% to about 0.75% by weight of the composition.
[0169] Non-limiting examples of preservatives can be salicylates or acids, benzoates or acids, etc. Non-limiting examples of preservatives can be sodium salicylate, sodium benzoate, potassium salicylate, potassium benzoate, salicylic acid, benzoic acid, MEA salicylate, MEA-benzoate, -TEA salicylate, TEA-TEA benzoate, calcium salicylate, calcium benzoate, magnesium salicylate, magnesium benzoate, titanium salicylate, titanium benzoate, silver salicylate, silver benzoate, ammonium salicylate, ammonium benzoate, zinc salicylate, zinc benzoate, and combinations thereof.
[0170] Some additional suitable non-limiting examples of preservatives include metal pyrithiones, organic acids (including but not limited to undecylenic acid, salicylic acid, dehydroacetic acid, sorbic acid), glycols (including but not limited to caprylyl glycol, decline glycol), parabens, methylchloroisothiazolinone, benzyl alcohol, ethylenediaminetetraacetic acid, and combinations thereof. Examples of commercially available preservative systems are provided under the trade names Geogard 111A™, Geoagard 221A™, Mikrokill COS™, Mikrokill ECT™, and Glycacil™. Suitable examples of high log S water-soluble preservatives can include sodium benzoate, methylisothiazolinone, DMDM hydantoin, and combinations thereof.
[0171] The present invention may be free of methylisothiazolinone, methylchloroisothiazolinone, 5-chloro-2-methyl-4-isothiazolin-3-one, and 2-methyl-4-isothiazolin-3-one, or the combination of 5-chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-4-isothiazolin-3-one commercially available as Kathon CG.
[0172] G. pH The personal cleansing composition of the present invention may have a pH of about 5 to about 7. The personal cleansing composition of the present invention may have a pH of about 5 to about 6. The personal cleansing composition of the present invention may have a pH of about 5.5 to about 6.5.
[0173] When making the personal cleansing compositions of the present invention, citric acid can be used to lower the pH of the composition in order to increase viscosity.
[0174] It may be desirable for consumers to have a personal cleansing composition that contains the minimum concentration of ingredients.The personal cleansing composition may be composed of 11 or less ingredients, 10 or less ingredients, 9 or less ingredients, 8 or less ingredients, 7 or less ingredients, 6 or less ingredients.The minimum ingredient formula may include water, anionic surfactant, cationic polymer, amphoteric surfactant, stabilizing polymer, zinc pyrithione, preservative, and fragrance.It is understood that fragrance may be formed from one or more materials.
[0175] H. Optional ingredients In the present invention, the personal cleansing composition may further comprise one or more optional ingredients, including benefit agents.Suitable benefit agents include, but are not limited to, conditioning agents, cationic polymers, silicone emulsions, antidandruff agents, gel networks, chelating agents, and natural oils such as sunflower oil or castor oil.Further suitable optional ingredients include, but are not limited to, perfumes, perfume microcapsules, colorants, particles, antibacterial agents, foam busters, antistatic agents, rheology modifiers and thickeners, suspending materials and structuring agents, pH adjusters and buffers, preservatives, pearlescent agents, solvents, diluents, antioxidants, vitamins, and combinations thereof.The composition may have about 0.5% to about 7% perfume.
[0176] Such optional ingredients should be physically and chemically compatible with the components of the composition and should not otherwise unduly impair the stability, aesthetics, or performance of the product. The CTFA Cosmetic Ingredient Handbook, Tenth Edition (published by the Cosmetic, Toiletry, and Fragrance Association, Inc. (Washington, DC)) (2004) (hereinafter "CTFA") describes a variety of non-limiting materials that may be added to the compositions herein.
[0177] 1. Conditioning agents The conditioning agent of the personal cleansing composition can be a silicone conditioning agent. The silicone conditioning agent can include volatile silicone, non-volatile silicone, or a combination thereof. The concentration of the silicone conditioning agent is typically in the range of about 0.01% to about 10%, about 0.1% to about 8%, about 0.1% to about 5%, and / or about 0.2% to about 3% by weight of the composition. Non-limiting examples of suitable silicone conditioning agents and optional suspending agents for silicones are described in U.S. Reissue Patent No. 34,584, U.S. Patent No. 5,104,646, and U.S. Patent No. 5,106,609, which are incorporated herein by reference.
[0178] Silicone conditioning agents for use in the compositions of the present invention may have a viscosity of from about 20 to about 2,000,000 centistokes ("csk"), from about 1,000 to about 1,800,000 csk, from about 10,000 to about 1,500,000 csk, and / or from about 20,000 to about 1,500,000 csk, when measured at 25°C.
[0179] The dispersed silicone conditioning agent particles typically have a volume average particle size ranging from about 0.01 micrometers to about 60 micrometers. When small particles are applied to hair, the volume average particle size typically ranges from about 0.01 micrometers to about 4 micrometers, from about 0.01 micrometers to about 2 micrometers, from about 0.01 micrometers to about 0.5 micrometers.
[0180] Further information on silicones, including sections discussing silicone fluids, rubbers, and resins, and the manufacture of silicones, can be found in Encyclopedia of Polymer Science and Engineering, vol. 15, 2d ed., pp 204-308, John Wiley & Sons, Inc. (1989), incorporated herein by reference.
[0181] Suitable silicone emulsions for use in the present invention include, but are not limited to, emulsions of insoluble polysiloxanes.They can be prepared through emulsion polymerization according to the description provided in US Patent No. 6,316,541, or US Patent No. 4,476,282, or US Patent Application Publication No. 2007 / 0276087, or they can be emulsified after polymerization is completed through various emulsification methods as described in US Patent No. 9,255,184 (B2), or US Patent No. 7,683,119, or Emulsions and Emulsion Stability, edited by Johan Sjoblom, CRC Press, 2005.These references allow for a non-limiting list of suitable emulsifiers and emulsifier blends to be considered based on the functionality of silicone used, emulsification method, and desired emulsion particle size. Thus, suitable insoluble polysiloxanes include polysiloxanes such as alpha, omega hydroxy terminated polysiloxanes or alpha, omega alkoxy terminated polysiloxanes having an internal phase viscosity of about 5 csk to about 500,000 csk. For example, the insoluble polysiloxane may have an internal phase viscosity of less than 400,000 csk, less than 200,000 csk, about 10,000 csk to about 180,000 csk. The insoluble polysiloxane may have an average particle size in the range of about 10 nm to about 10 micrometers. The average particle size may be, for example, in the range of about 15 nm to about 5 micrometers, about 20 nm to about 1 micrometer, about 25 nm to about 550 nm, or about 1 to 10 micrometers. The concentration of dispersed silicone in the emulsion may be in the range of about 5 to 90 percent by weight, or 20 to 85 percent by weight, or 30 to 80 percent by weight of the emulsion composition.
[0182] The average molecular weight of the insoluble polysiloxane, the internal phase viscosity of the insoluble polysiloxane, the viscosity of the silicone emulsion and the size of the particles containing the insoluble polysiloxane are measured by methods widely used by those skilled in the art, such as the method disclosed in Smith, AL The Analytical Chemistry of Silicones, John Wiley & Sons, Inc.: New York, 1991. For example, the viscosity of the silicone emulsion can be measured at 30°C using a Brookfield viscometer equipped with spindle 6 at 2.5 rpm. The silicone emulsion may further include an additional emulsifier together with the anionic surfactant.
[0183] Other classes of silicones suitable for use in the compositions of the present invention include, but are not limited to, i) silicone fluids (including but not limited to silicone oils), which are flowable materials having a viscosity of less than about 1,000,000 csk when measured at 25° C.; ii) aminosilicones, which contain at least one primary, secondary, or tertiary amine; iii) cationic silicones, which contain at least one quaternary ammonium functional group; iv) silicone gums, which include materials having a viscosity of 1,000,000 csk or more when measured at 25° C.; v) silicone resins, which include highly crosslinked polymeric siloxane systems; vi) high refractive index silicones, which have a refractive index of at least 1.46, and vii) mixtures thereof.
[0184] The conditioning agent of the personal cleansing composition of the present invention may also further comprise at least one organic conditioning material, such as oil or wax, alone or in combination with other conditioning agents, such as silicones, as described above. The organic material may be non-polymeric, oligomeric, or polymeric. It may be in the form of oil or wax, and may be added to the formulation as is or in pre-emulsified form. Some non-limiting examples of organic conditioning materials may include, but are not limited to, i) hydrocarbon oils, ii) polyolefins, iii) fatty esters, iv) fluorinated conditioning compounds, v) fatty alcohols, vi) alkylglucosides and alkylglucoside derivatives, vii) quaternary ammonium compounds, viii) polyethylene glycols and polypropylene glycols having molecular weights up to about 2,000,000, including those with CTFA designations PEG-200, PEG-400, PEG-600, PEG-1000, PEG-2M, PEG-7M, PEG-14M, PEG-45M, and mixtures thereof.
[0185] 2. Emulsifiers Various anionic and nonionic emulsifiers can be used in the personal cleansing composition of the present invention.Anionic and nonionic emulsifiers can be either monomeric or polymeric in nature.Examples of monomers include, but are not limited to, alkyl ethoxylates, alkyl sulfates, soaps, and fatty acid esters, and their derivatives.Examples of polymers include, but are not limited to, polyacrylates, polyethylene glycols, and block copolymers, and their derivatives.Naturally occurring emulsifiers such as lanolin, lecithin, and lignin, and their derivatives are also non-limiting examples of useful emulsifiers.
[0186] 3. Chelating Agents The personal cleansing composition may also further comprise a chelating agent.Suitable chelating agents include those described in AE Martell&R M Smith, Critical Stability Constants, Vol.1, Plenum Press, New York&London (1974) and AE Martell&R D Hancock, Metal Complexes in Aqueous Solution, Plenum Press, New York&London (1996), both of which are incorporated herein by reference.With respect to chelating agents, the term "salts and their derivatives" refers to salts and derivatives that contain the same functional structure (e.g., the same chemical backbone) as the chelating agent being referred to, and have similar or better chelating properties.This term includes alkali metal, alkaline earth, ammonium, substituted ammonium salts (i.e., monoethanolammonium, diethanolammonium, triethanolammonium) salts, esters of chelating agents with acidic moieties, and mixtures thereof, specifically all sodium, potassium or ammonium salts. The term "derivative" also includes "chelating surfactant" compounds such as those exemplified in U.S. Pat. No. 5,284,972, and larger molecules containing one or more chelating groups with the same functional structure as the parent chelator, such as the polymer EDDS (ethylenediaminedisuccinic acid) disclosed in U.S. Pat. No. 5,747,440.
[0187] Chelating agents can be incorporated into the compositions described herein in amounts ranging from 0.001% to 10.0% by weight of the total composition, from about 0.01% to 2.0%.
[0188] Non-limiting classes of chelating agents include carboxylic acids, aminocarboxylic acids, such as aminocids, phosphoric acids, phosphonic acids, polyphosphonic acids, polyethyleneimines, polyfunctionally substituted aromatics, derivatives and salts thereof.
[0189] Non-limiting chelating agents include the following materials and their salts: ethylenediaminetetraacetic acid (EDTA), ethylenediaminetriacetic acid, ethylenediamine-N,N'-disuccinic acid (EDDS), ethylenediamine-N,N'-diglutaric acid (EDDG), salicylic acid, aspartic acid, glutamic acid, glycine, malonic acid, histidine, diethylenetriaminepentaacetate (DTPA), N-hydroxyethylethylenediaminetriacetate, nitrilotriacetate, ethylenediaminetetrapropionate, trisodium EDTA, tetrahydrofuran ... Ethylenetetraaminehexaacetate, ethanol diglycine, propylenediaminetetraacetic acid (PDTA), methylglycine diacetate (MODA), diethylenetriaminepentaacetic acid, methylglycine diacetate (MGDA), N-acyl-N,N',N'-ethylenediaminetriacetic acid, nitrilotriacetic acid, ethylenediaminediglutaric acid (EDGA), 2-hydroxypropylenediaminedisuccinic acid (HPDS), glycinamide-N,N'-disuccinic acid (GADS), 2-Hydroxypropylenediamine-N,N'-disuccinic acid (HPDDS), N-2-hydroxyethyl-N,N-diacetic acid, glyceryl iminodiacetic acid, iminodiacetic acid-N-2-hydroxypropyl sulfonic acid, aspartic acid N-carboxymethyl-N-2-hydroxypropyl-3-sulfonic acid, alanine-N,N'-diacetic acid, aspartic acid-N,N'-diacetic acid, aspartic acid N-monoacetic acid, iminodisuccinic acid, diamine-N,N'-dipolyacid, monoa diaminoalkyldi(sulfosuccinate) (DDS), ethylenediamine-N,N'-bis(ortho-hydroxyphenylacetic acid), N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid, ethylenediaminetetraproprionate, triethylenetetraaminehexaacetate, diethylenetriaminepentaacetate, dipicolinic acid, ethylenediaminedicysteic acid (EDC), ethylenediamine-N,N'-bis(2-hydroxyphenylacetic acid) (EDDHA), glutamic acid diacetate (GLDA), hexadentate aminocarboxylates (HBED), polyethyleneimine, 1-hydroxydiphosphonates, aminotri(methylenephosphonic acid) (ATMP), nitrilo trimethylene phosphonates (NTP), ethylenediamine tetramethylene phosphonates, diethylenetriamine pentamethylene phosphonates (DTPMP), ethane-1-hydroxydiphosphonates (HEDP), 2-phosphonobutane-1,2,4-tricarboxylic acid, polyphosphoric acid, sodium tripolyphosphate, tetrasodium diphosphate, hexametaphosphoric acid, sodium metaphosphate, phosphonic acids and derivatives, amino alkylene-poly(alkylene phosphonic acid), amino tri(1-ethylphosphonic acid), ethylenediamine tetra(1-ethylphosphonic acid), amino tri(1-propylphosphonic acid), Aminotri(isopropylphosphonic acid), ethylenediaminetetra(methylenephosphonic acid) (EDTMP), 1,2-dihydroxy-3,5-disulfobenzene, 1-hydroxypyridinone, 2-pyridinol-N-oxide, and combinations thereof.
[0190] I. Aqueous Carriers The personal cleansing composition may be in the form of a pourable liquid (under ambient conditions). Thus, such compositions typically include a carrier, which is present at a concentration of about 40% to about 85% by weight of the personal cleansing composition, alternatively about 45% to about 80% by weight, alternatively about 50% to about 75% by weight. The carrier may include water or a miscible mixture of water and an organic solvent, and in one embodiment, may include water with minimal or no significant concentration of organic solvent, except when accidentally incorporated into the composition as a minor component of other essential or optional components.
[0191] Carriers that may be useful in the personal cleansing composition of the present invention may include water and aqueous solutions of lower alkyl alcohols and polyhydric alcohols.The lower alkyl alcohols useful herein are monohydric alcohols having 1-6 carbons, in one embodiment, ethanol and isopropanol.Exemplary polyhydric alcohols useful herein include propylene glycol, hexylene glycol, glycerin, and propanediol.
[0192] J. Product form The personal cleansing composition of the present invention can be present in a typical hair care formulation.The composition can be in the form of a solution, dispersion, emulsion, powder, talc, capsule, sphere, sponge, solid dosage form, foam, and other delivery mechanisms.The composition of the present invention can be in the form of leave-on hair products, such as hair tonics, treatment and styling products, rinse-off hair products, such as shampoos and personal cleansing products, and treatment products, and any other form that can be applied to hair.
[0193] K. Methods of Making Cleansing Compositions The cleansing composition described herein can be formed similarly to known cleansing compositions.For example, the process of making the cleansing composition can include mixing a surfactant, a cationic polymer, zinc pyrithione, and a liquid carrier together to form the cleansing composition.
[0194] L. Method Viscosity measurement The viscosity of the personal cleansing composition was measured using a cone and plate Brookfield RS rheometer equipped with cone C75-1 at 2s -1 The measurements can be performed on a 2.5 mL sample at a constant shear rate of 100 Hz, at 27° C. for 3 minutes.
[0195] The personal cleansing composition of the present invention may have a viscosity of greater than about 5000 cps (centipoise). The personal cleansing composition may have a viscosity of about 5000 to about 50,000 cps, the personal cleansing composition may have a viscosity of about 6000 to about 15,000 cps, and the personal cleansing composition may have a viscosity of about 7000 to about 10,000 cps.
[0196] Antibacterial Efficacy Testing The following method is based on European Pharmacopoeia 5.1.3 "Efficacy of Antimicrobial Preservation." A bacterial pool consisting of equal parts each of K. pneumoniae, E. gergoviae, S. marcescens, S. aureus, P. aeruginosa, E. coli, and B. cepacia was inoculated into shampoo compositions and saline controls to achieve a 5.0-7.0 log 10 Deliver a target bioburden of cfu / mL. After incubation at room temperature for 2, 7, 14, and 28 days, the inoculated composition and saline control are diluted in modified Leithen Broth (Becton Dickinson, Cat. No. 263010) + polysorbate 80. The solutions are plated in triplicate on tryptic soy agar (Becton Dickinson, Cat. No. 255320) with lecithin and polysorbate 80, and colony forming units (cfu) are counted after incubation periods of 1 to 3 days at 33°C.
[0197] The following method is based on European Pharmacopoeia 5.1.3 "Efficacy of Antimicrobial Preservation". A yeast / mold pool consisting of equal parts each of C. albicans and A. brasiliensis was inoculated into the shampoo composition and saline control to obtain a 5.0 to 7.0 log 10Deliver a target bioburden of cfu / mL. After incubation at room temperature for 2, 7, 14, and 28 days, the inoculated composition and saline control are diluted in modified Leithen Broth (Becton Dickinson, Cat. No. 263010) + polysorbate 80. The solutions are plated in triplicate on tryptic soy agar (Becton Dickinson, Cat. No. 255320) with lecithin and polysorbate 80, and colony forming units (cfu) are counted after incubation periods of 1 to 3 days at 33°C.
[0198] Logarithmic Decrease Calculation The pour plate data is averaged and multiplied by the dilution factor to calculate the average microbial cfu per mL, as shown in the sample calculation below. The log reduction of microorganisms is calculated by dividing the cfu per mL of the saline control on day 2 by the cfu per mL of the composition, and taking the log of the quotient. 10 The log reduction is calculated by taking the log of the composition relative to the saline control. Based on the variability of antibacterial efficacy testing, a difference of 0.5 or more log reduction between compositions is considered to be a significant difference.
[0199] Alternatively, another conventional method for calculating the log reduction of a composition is to dilute the inoculum at the time of inoculation and count the colonies after appropriate incubation on growth agar. The resulting cfu per mL of inoculum is used in place of the saline control in the numerator of the equation to calculate the log reduction.
[0200] Net change in logarithmic reduction calculation The net change in microbial log reduction can be calculated by subtracting the log reduction of the unpreserved control from the log reduction of the shampoo composition.
[0201] Pass / Fail Criteria Success criteria (pass / fail) for preservative efficacy are based on European Pharmacopoeia Table 5.1.3-2 "topical preparations" and are defined in the first column of each of the results tables. The log reduction requirements for bacterial inoculum are at least 2-log on day 2, 3-log on day 7, with no increase from previous time points on day 28, and the log reduction for yeast / mold inoculum is 2-log on day 14, with no increase from previous time points on day 28.
[0202] Sample calculation: Logarithmic Decrease
[0203] [Table 1]
[0204]
number
[0205] Net logarithmic change
[0206] [Table 2]
[0207]
number
[0208] M.Results
[0209] [Table 3]
[0210] Example sources: 1.Mackam DAB ULS, Supplier: Solvay 2.Hostapon SCI-85 C, supplier:Clariant 3. UCARE Polymer LR-30M, Supplier: Dow 4.Rheocare TTA, supplier: BASF 5. Zinc Pyrithione (ZPT), 40% active, supplied by Arch Chemicals 6. Sodium Benzoate Dense NF / FCC, Supplier: Emerald Performance Materials 7. Sodium Salicylate, Supplier: JQC(Huayin)Pharmaceutical Co.,Ltd. 8. Citric Acid Anhydrous, Supplier: Archer Daniels Midland; concentration can be adjusted to achieve target pH
[0211] [Table 4]
[0212] [Table 5]
[0213] Example sources: 1.Mackam DAB ULS, Supplier: Solvay 2.Hostapon SCI-85 C, supplier:Clariant 3. UCARE Polymer LR-30M, Supplier: Dow 4.Rheocare TTA, supplier: BASF 5. Zinc Pyrithione (ZPT), 40% active, supplied by Arch Chemicals 6. Sodium Benzoate Dense NF / FCC, Supplier: Emerald Performance Materials 7. Sodium Salicylate, Supplier: JQC(Huayin)Pharmaceutical Co.,Ltd. 8. Citric Acid Anhydrous, Supplier: Archer Daniels Midland; concentration can be adjusted to achieve target pH
[0214] N. Discussion Evaluation of a product's micro-robustness involves testing the formulation via an antibacterial efficacy test and estimating its ability to reduce a broad range of microorganisms (bacteria, yeast, mold) over time (2 days, 7 days, 14 days, 28 days) against established success criteria (pass / fail).
[0215] The initial 14 day micro-robustness testing shows that low concentrations of two preservatives added to batches without ZPT (Example 3) or single preservative options (sodium benzoate, sodium salicylate) do not meet the antibacterial efficacy testing criteria (Examples 4, 5, 6, 7). The combination of ZPT and preservatives with fragrance meets the success criteria (Example 8) (pass / fail). An additional 28 day experiment will be conducted to determine which ingredients and ingredient combinations provide micro-robustness.
[0216] A 28 day antibacterial efficacy study shows that the success criteria (Examples 9, 11, 12, 13, 14) (pass / fail) are met by including ZPT in the formulation with either sodium benzoate or sodium salicylate at sufficient concentrations.
[0217] E. Combination A. A personal cleansing composition comprising: a) from about 6% to about 50% of one or more sulfate-free surfactants; b) about 0.5% to 20% lauramidopropyl betaine; c) about 0.1% to about 10% zinc pyrithione; d) about 0.05% to about 3% of a cationic polymer; e) about 0.05% to 10% of a stabilizing polymer; f) containing about 0.1% to about 2% of a preservative; A personal cleansing composition having a pH of about 5 to about 7. B. The personal cleansing composition of paragraph A, wherein the personal cleansing composition comprises from about 0.3% to about 1.5% of a preservative. C. The personal cleansing composition of paragraphs A-B, wherein the personal cleansing composition comprises from about 0.45% to about 0.75% of a preservative. D. The personal cleansing composition of paragraphs A-C, wherein the personal cleansing composition does not include methylisothiazolinone, methylchloroisothiazolinone, 5-chloro-2-methyl-4-isothiazolin-3-one, 2-methyl-4-isothiazolin-3-one, and a combination of 5-chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-4-isothiazolin-3-one. E. The personal cleansing composition of paragraphs A-D, wherein the personal cleansing composition has a viscosity of greater than about 5000 cps. F. The personal cleansing composition of paragraphs A-E, wherein the one or more sulfate-free surfactants are selected from the group consisting of sodium, ammonium, or potassium isethionates; sodium, ammonium, or potassium sulfonates; sodium, ammonium, or potassium ether sulfonates; sodium, ammonium, or potassium sulfosuccinates; sodium, ammonium, or potassium sulfoacetates; sodium, ammonium, or potassium glycinates; sodium, ammonium, or potassium sarcosinates; sodium, ammonium, or potassium glutamates; sodium, ammonium, or potassium alaninates; sodium, ammonium, or potassium carboxylates; sodium, ammonium, or potassium taurates; sodium, ammonium, or potassium phosphate esters; and combinations thereof. G. Stabilizing polymers include acrylamide / ammonium acrylate copolymer (and) polyisobutene (and) polysorbate 20; acrylamide / sodium acryloyldimethyltaurate copolymer / isohexadecane / polysorbate 80, ammonium acryloyldimethyltaurate / VP copolymer, sodium acrylate / sodium acryloyldimethyltaurate copolymer, acrylates copolymer, acrylates crosspolymer-4, acrylates crosspolymer-3, acrylates / beheneth-25 methacrylate copolymer, acrylates / C10-C30 alkyl acrylate crosspolymer, acrylates / steareth-20 itaconate copolymer, ammonium polyacrylate / isohexadecane / PEG 40 Castor oil; carbomer, sodium carbomer, crosslinked polyvinylpyrrolidone (PVP), polyacrylamide / C13-14 isoparaffin / laureth-7, polyacrylate 13 / polyisobutene / polysorbate 20, polyacrylate crosspolymer-6, polyamide-3, polyquaternium-37 (and) hydrogenated polydecene (and) trideceth-6, acrylamide / sodium acryloyldimethyltaurate / acrylic acid copolymer, sodium acrylate / acryloyldimethyltaurate / dimethylacrylamide, crosspolymer (and) isohexadecane (and) polysorbate 60, sodium polyacrylate, and mixtures thereof. H. The personal cleansing composition of paragraphs A-G, wherein the preservative is selected from the group consisting of sodium salicylate, sodium benzoate, potassium salicylate, potassium benzoate, salicylic acid, benzoic acid, MEA-salicylate, MEA-benzoate, TEA-salicylate, TEA-benzoate, calcium salicylate, calcium benzoate, magnesium salicylate, magnesium benzoate, titanium salicylate, titanium benzoate, silver salicylate, silver benzoate, ammonium salicylate, ammonium benzoate, zinc salicylate, zinc benzoate, undecylenic acid, dehydroacetic acid, sorbic acid, glycol, caprylyl glycol, decline glycol, parabens, methylchloroisothiazolinone, methylisothiazolinone, benzyl alcohol, ethylenediaminetetraacetic acid, and combinations thereof. I. The personal cleansing composition of paragraphs AH, wherein the preservative is sodium salicylate. J. The personal cleansing composition of paragraphs AI, wherein the preservative is sodium benzoate. K. The personal cleansing composition of paragraphs A-J, further comprising an amphoteric surfactant selected from the group consisting of betaines, sultaines, hydroxysultanes, amphohydroxypropylsulfonates, alkyl amphoacetates, alkyl amphodiacetates, and combinations thereof. L. The personal cleansing composition of paragraphs A-K, wherein the cationic polymer is selected from the group consisting of cationic guar, cationic cellulose, cationic synthetic homopolymer, cationic synthetic copolymer, and combinations thereof. M. The personal cleansing composition of paragraphs A-L, wherein the cationic polymer is selected from the group consisting of hydroxypropyltrimonium guar, polyquaternium 10, polyquaternium 6, and combinations thereof. N. The personal cleansing composition of paragraphs A-M, wherein the cationic polymer is Polyquaternium 10. O. The personal cleansing composition of paragraphs A-N, wherein the pH of the composition is from about 5 to about 6. P. The personal cleansing composition of paragraphs A-O, wherein the pH of the composition is from about 5.5 to about 6.5. Q. The personal cleansing composition of paragraphs A-P, having a viscosity of from about 5,000 cps to about 50,000 cps. R. The personal cleansing composition of paragraphs A-Q, wherein the composition consists of nine or fewer ingredients.
[0218] It is understood that other modifications of the present disclosure are within the scope of those skilled in the art of personal cleansing formulations and can be made without departing from the spirit and scope of the present invention.All parts, percentages and ratios herein are by weight unless otherwise specified.Some components may be provided as dilute solutions from the source.The concentrations listed represent the weight percent of actives unless otherwise specified.Fragrance and / or preservative concentrations may also be included in the following examples.
[0219] In the examples, unless otherwise specified, all concentrations are listed as weight percent and may exclude minor materials such as diluents, fillers, etc. Thus, the listed formulation includes the listed components and any minor materials associated with such components. As will be apparent to one skilled in the art, the selection of these minor materials will depend on the physical and chemical properties of the particular ingredients selected to make the personal cleansing composition.
[0220] The dimensions and values disclosed herein should not be understood as being strictly limited to the exact numerical values recited. Instead, unless otherwise specified, each such dimension is intended to mean both the recited value and a functionally equivalent range surrounding that value. For example, a dimension disclosed as "40 mm" is intended to mean "about 40 mm."
[0221] All documents cited herein, including cross-referenced documents or related patents or applications, are incorporated herein by reference in their entirety unless expressly excluded or specifically limited. The citation of any document shall not be deemed to be prior art to any invention disclosed or claimed herein, or to teach, suggest or disclose such invention, either alone or in combination with any other reference(s). Furthermore, to the extent that any meaning or definition of a term in this document conflicts with any meaning or definition of the same term in a document incorporated by reference, the meaning or definition assigned to that term in this document shall govern.
[0222] While particular embodiments of the present invention have been illustrated and described, it would be obvious to those skilled in the art that various other changes and modifications can be made without departing from the spirit and scope of the invention. It is therefore intended to cover in the appended claims all such changes and modifications that are within the scope of this invention.
Claims
1. 1. A personal cleansing composition comprising: a) 6% to 50% of one or more sulfate-free surfactants; b) 0.5% to 20% lauramidopropyl betaine; c) 0.1% to 10% zinc pyrithione; d) 0.05% to 3% of a cationic polymer; e) 0.05% to 10% of a stabilizing polymer; f) 0.1% to 2% preservatives and having a pH of 5 to 7.
2. 10. The personal cleansing composition of claim 1 comprising from 0.3% to 1.5% preservative, preferably from 0.45% to 0.75% preservative.
3. 3. The personal cleansing composition of claim 1, which is free of methylisothiazolinone, methylchloroisothiazolinone, 5-chloro-2-methyl-4-isothiazolin-3-one, 2-methyl-4-isothiazolin-3-one, and a combination of 5-chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-4-isothiazolin-3-one.
4. The personal cleansing composition of any one of claims 1 to 3 having a viscosity of greater than 5000 cps.
5. 5. The personal cleansing composition of claim 1, wherein the one or more sulfate-free surfactants are selected from the group consisting of sodium, ammonium, or potassium isethionates; sodium, ammonium, or potassium sulfonates; sodium, ammonium, or potassium ether sulfonates; sodium, ammonium, or potassium sulfosuccinates; sodium, ammonium, or potassium sulfoacetates; sodium, ammonium, or potassium glycinates; sodium, ammonium, or potassium sarcosinates; sodium, ammonium, or potassium glutamates; sodium, ammonium, or potassium alaninates; sodium, ammonium, or potassium carboxylates; sodium, ammonium, or potassium taurates; sodium, ammonium, or potassium phosphate esters; and combinations thereof.
6. The stabilizing polymer is selected from the group consisting of acrylamide / ammonium acrylate copolymer (and) polyisobutene (and) polysorbate 20; acrylamide / sodium acryloyldimethyltaurate copolymer / isohexadecane / polysorbate 80, ammonium acryloyldimethyltaurate / VP copolymer, sodium acrylate / sodium acryloyldimethyltaurate copolymer, acrylates copolymer, acrylates crosspolymer-4, acrylates crosspolymer-3, acrylates / beheneth-25 methacrylate copolymer, acrylates / C10-C30 alkyl acrylate crosspolymer, acrylates / steareth-20 itaconate copolymer, ammonium polyacrylate / isohexadecane / PEG-40 hyaluronate copolymer, and the like.
6. The personal cleansing composition of any one of claims 1 to 5, wherein the active ingredient is selected from the group consisting of: maltose oil; carbomer, sodium carbomer, crosslinked polyvinylpyrrolidone (PVP), polyacrylamide / C13-14 isoparaffin / laureth-7, polyacrylate 13 / polyisobutene / polysorbate 20, polyacrylate crosspolymer-6, polyamide-3, polyquaternium-37 (and) hydrogenated polydecene (and) trideceth-6, acrylamide / sodium acryloyldimethyltaurate / acrylic acid copolymer, sodium acrylate / acryloyldimethyltaurate / dimethylacrylamide, crosspolymer (and) isohexadecane (and) polysorbate 60, sodium polyacrylate, and mixtures thereof.
7. 7. The personal cleansing composition of any one of claims 1 to 6, wherein the preservative is selected from the group consisting of sodium salicylate, sodium benzoate, potassium salicylate, potassium benzoate, salicylic acid, benzoic acid, MEA-salicylate, MEA-benzoate, TEA-salicylate, TEA-benzoate, calcium salicylate, calcium benzoate, magnesium salicylate, magnesium benzoate, titanium salicylate, titanium benzoate, silver salicylate, silver benzoate, ammonium salicylate, ammonium benzoate, zinc salicylate, zinc benzoate, undecylenic acid, dehydroacetic acid, sorbic acid, glycol, caprylyl glycol, decline glycol, parabens, methylchloroisothiazolinone, methylisothiazolinone, benzyl alcohol, ethylenediaminetetraacetic acid, and combinations thereof.
8. A personal cleansing composition according to any preceding claim, wherein the preservative is sodium salicylate.
9. A personal cleansing composition according to any preceding claim, wherein the preservative is sodium benzoate.
10. 10. The personal cleansing composition of claim 1, further comprising an amphoteric surfactant selected from the group consisting of betaines, sultaines, hydroxysultanes, amphohydroxypropylsulfonates, alkyl amphoacetates, alkyl amphodiacetates, and combinations thereof.
11. 11. The personal cleansing composition of any one of claims 1 to 10, wherein the cationic polymer is selected from the group consisting of cationic guar, cationic cellulose, cationic synthetic homopolymers, cationic synthetic copolymers, and combinations thereof.
12. 12. The personal cleansing composition of any one of claims 1 to 11, wherein the cationic polymer is selected from the group consisting of hydroxypropyltrimonium guar, polyquaternium 10, polyquaternium 6, and combinations thereof, preferably, the cationic polymer is polyquaternium 10.
13. A personal cleansing composition according to any one of claims 1 to 12, wherein the pH of the composition is from 5 to 6, preferably from 5.5 to 6.
5.
14. 14. The personal cleaning composition of any one of claims 1 to 13, wherein the viscosity is from 5,000 cps to 50,000 cps.
15. A personal cleaning composition according to any one of claims 1 to 14, wherein the composition consists of 9 or fewer ingredients.
Citation Information
Patent Citations
Organic zinc compounded oil-control anti-dandruff shampoo and preparation method thereof
CN112402275A
Compositions containing anti-dandruff agents
US8574561B1
Sulfate free composition with enhanced deposition of scalp active
WO2021113583A1
